UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

  

Commission file number 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #ATCarmel By The SeaCA 93921
(Address of Principal Executive Offices, including zip code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   Accelerated Filer
Non-accelerated Filer   Smaller Reporting Company
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

Securities registered pursuant to Section 12(b) of the Act: n/a.

 

As of November 13, 2023, there were 13,319,889 shares of the Company’s common stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

 

Form 10-Q

For the Quarter Ended September 30, 2023

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 1
     
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the nine months ended September 30, 2023 and 2022 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (Unaudited) 4
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 29
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 37
     
Item 4. Controls and Procedures 37
     
Part II. Other Information 38
     
Item 1. Legal Proceedings 38
     
Item 1A. Risk Factors 39
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
     
Item 3. Defaults Upon Senior Securities 39
     
Item 4. Mine Safety Disclosures 39
     
Item 5. Other Information 39
     
Item 6. Exhibits 40
     
Signatures 41

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

  

  our ability to implement our business plan, including our ability to launch and generate revenue from our IPSIPay Express joint venture or other digital payment solutions we may seek to develop or commercialize in the future;

 

  acceptance by the marketplace of our products and services, notably IPSIPay Express;

 

our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

 

the viability of our current intellectual property and intellectual property created in the future;

 

our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

 

our ability to retain key employees and third-party service providers;

 

  adverse changes in general market conditions for payment solutions such as IPSIPay Express and other products and services we offer;

 

our ability to generate cash flow and profitability and continue as a going concern;

 

our future financing plans and ability to repay outstanding indebtedness; and

 

our ability to adapt to changes in market conditions which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this report and in the “Business,” “Risk Factors” and other sections of the 2022 Form 10-K. You should thoroughly read this report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this report relate only to events or information as of the date of this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect.

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
Assets        
Current Assets        
Cash  $19,395   $373,822 
Other current assets   49,414    97,042 
Assets held for sale   
-
    807,263 
Total Current Assets   68,809    1,278,127 
           
Non-current assets          
Plant and equipment   7,569    40,362 
Intangible assets   
-
    1,401,491 
Security deposit   15,000    32,592 
Equity method investment   704,330    
-
 
Total Non-Current Assets   726,899    1,474,445 
Total Assets  $795,708   $2,752,572 
           
Liabilities and Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $1,596,407   $727,922 
Liabilities held for sale   
-
    33,810 
Related party payables   50,000    
-
 
Federal relief loans – current portion   3,295    
-
 
Notes payable   1,037,371    964,268 
Convertible debt, net of unamortized discount of $744,914 and $0, respectively   3,455,937    2,266,602 
Derivative liability   1,341,932    2,550,642 
Total Current Liabilities   7,484,942    6,543,244 
           
Non-Current Liabilities          
Federal relief loans   158,273    163,978 
Total Non-Current Liabilities   158,273    163,978 
           
Total Liabilities   7,643,215    6,707,222 
           
Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,030,034 and 12,563,426 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.*   1,303    1,256 
Additional paid-in-capital*   50,013,798    48,442,355 
Accumulated deficit   (56,862,608)   (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders   (6,847,507)   (3,956,247)
Non-controlling interest   
-
    1,597 
Total Equity (Deficit)   (6,847,507)   (3,954,650)
Total Liabilities and Equity (Deficit)  $795,708   $2,752,572 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Revenue  $(28)  $
-
   $410   $
-
 
                     
Cost of Goods Sold   387    
-
    2,756    
-
 
                     
Gross loss   (415)   
-
    (2,346)   
-
 
                     
General and administrative   745,688    2,705,833    2,753,266    4,326,413 
Depreciation and amortization   100,387    20,500    380,092    29,493 
Total Expense   846,075    2,726,333    3,133,358    4,355,906 
                     
Loss from Operations   (846,490)   (2,726,333)   (3,135,704)   (4,355,906)
                     
Loss on debt conversion   (58,769)   

-

    (77,247)   
-
 
Penalty on convertible notes   (9,306)   (602,100)   (9,306)   (1,321,658)
Loss on novation   (1,066,165)   

-

    (1,066,165)   

-

 
Fair value of warrants issued   (14,176)   

-

    (14,176)   

-

 
Interest expense   (110,328)   (51,340)   (290,628)   (142,302)
Amortization of debt discount   (303,042)   
-
    (414,696)   (263,200)
Derivative liability movements   1,795,642    84,895    1,483,710    (65,046)
Loss before Income Taxes   (612,634)   (3,294,878)   (3,524,212)   (6,148,112)
                     
Income Taxes   

-

    
-
    
-
    
-
 
Net Loss after income taxes   (612,634)   (3,294,878)   (3,524,212)   (6,148,112)
                     
Net loss from equity method investments   (402,509)   
-
    (403,890)   
-
 
Net loss from continuing operations   (1,015,143)   (3,294,878)   (3,928,102)   (6,148,112)
                     
Discontinued operations                    
Operating loss from discontinued operations   
-
    (15,618)   (40,821)   (59,962)
Loss on disposal of subsidiary and investment   
-
    
-
    (495,424)   
-
 
    
-
    (15,618)   (536,245)   (59,962)
Net loss   (1,015,143)   (3,310,496)   (4,464,347)   (6,208,074)
Net loss attributable to non-controlling interest   
-
    7,652    1,597    29,381 
Net loss attributable to Innovative Payment Solutions, Inc., stockholders  $(1,015,143)  $(3,302,844)  $(4,462,750)  $(6,178,693)
                     
Basic and diluted loss per share*                    
Continuing operations*
  $(0.08)  $(0.26)  $(0.31)  $(0.50)
Discontinued operations*
   0.00    0.00    (0.04)   0.00 
 
  $(0.08)  $(0.26)  $(0.35)  $(0.50)
Weighted Average Number of Shares Outstanding – Basic and diluted*
   12,789,493    12,531,868    12,650,758    12,353,866 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-controlling
shareholders
interest
   Total
Stockholders’
Equity (Deficit)
 
Balance at December 31, 2022   
        -
   $
       -
    12,563,426   $1,256   $48,442,355   $(52,399,858)  $1,597   $(3,954,650)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    251,856    
-
    
-
    251,856 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
    -    
-
    
-
    (273,390)   (1,597)   (274,987)
Balance at March 31, 2023   
-
   $
-
    12,563,426   $1,256   $48,824,882   $(52,673,248)  $
-
   $(3,847,110)
Conversion of convertible debt   
-
    
-
    72,464    7    43,471    
-
    
-
    43,478 
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    130,025    
-
    
-
    130,025 
Fair value of warrants issued for equity method investments   -    
-
    -    
-
    108,220    
-
    
-
    108,220 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
         
 
    
 
    (3,174,217)   
-
    (3,174,217)
Balance as of June 30, 2023   
-
   $
-
    12,635,890   $1,263   $49,237,269   $(55,847,465)  $
-
   $(6,608,933)
Conversion of convertible debt   
-
    
-
    391,306    40    193,729    
-
    
-
    193,769 
Additional shares issued on reverse stock split   
-
    -    2,838    -    -    -    -    - 
Fair value of warrants issued for services   -    
-
    -    
-
    14,176    
-
    
-
    14,176 
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    437,953    
-
    
-
    437,953 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
    

-

    

-

    

-

    (1,015,143)   
-
    (1,015,143)
Balance at September 30, 2023   
 
    
 
    13,030,034    1,303    50,013,798    (56,862,608)   
-
    (6,847,507)

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-controlling
shareholders
interest
   Total
Stockholders’
Equity (Deficit)
 
Balance at December 31, 2021   
        -
    
         -
    12,263,426   $1,226   $45,806,576   $(42,111,701)  $35,211   $3,731,312 
Stock based option expense   -    
-
    -    
-
    94,466    
-
    
-
    94,466 
Restricted stock awards   -    
-
    -    
-
    62,766    
-
    
-
    62,766 
Net loss   -    
-
    -    
-
    
-
    (1,801,494)   (8,752)   (1,810,246)
Balance at March 31, 2022   
-
   $
-
    12,263,426   $1,226   $45,963,808   $(43,913,195)  $26,459   $2,078,298 
Contribution by minority shareholders   

-

    

-

    

-

    

-

    

-

    

-

    9,653    9,653 
Stock based option expense   -    
-
    -    
-
    94,462    
-
    
-
    94,462 
Restricted stock awards   -    
-
    -    
-
    62,766    
-
    
-
    62,766 
Net loss   -    
-
    -    
-
    
-
    (1,074,355)   (12,977)   (1,087,332)
Balance at June 30, 2022   

-

    

-

    12,263,426    1,226    46,121,036    (44,987,550)   23,135    1,157,847 
Fair value of warrants issued   

-

    

-

    

-

    

-

    322,918    

-

    

-

    322,918 
Shares issued for services   

-

    

-

    233,333    23    332,977    

-

    

-

    333,000 
Restricted stock awards   

-

    

-

    66,667    7    109,993    

-

    

-

    110,000 
Stock based option expense   

-

    

-

    

-

    

-

    1,013,056    

-

    

-

    1,013,056 
Net loss   

-

    

-

    

-

    

-

    

-

    (3,302,844)   (7,652)   (3,310,496)
Balance at September 30, 2022   
-
   $
-
    12,563,426   $1,256   $47,899,980   $(48,290,394)  $15,483   $373,675 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to condensed consolidated financial statements.

 

3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Nine months
ended
   Nine months
ended
 
   September 30,   September 30, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(4,464,347)  $(6,208,074)
Net loss from discontinued operations   536,245    59,962 
Net loss from continuing operations   (3,928,102)   (6,148,112)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   (1,483,710)   65,046 
Depreciation   380,092    29,493 
Amortization of debt discount   414,696    263,200 
Loss on novation   1,066,165    
-
 
Loss on conversion of debt to equity   77,247    
-
 
Penalty on convertible debt   9,306    1,321,658 
Unrealized loss on equity method investments   403,890    
-
 
Shares issued for services   
-
    333,000 
Stock based compensation   283,392    1,437,516 
Fair value of warrants issued   122,797    322,918 
Changes in Assets and Liabilities          
Other current assets   47,628    (48,846)
Accounts payable and accrued expenses   1,150,919    126,111 
Related party payables   50,000    
-
 
Interest accruals   281,383    54,042 
Cash used in operating activities – continuing operations   (1,124,297)   (2,243,974)
Cash provided by (used in) operating activities – discontinued operations   35,286    (76,452)
CASH USED IN OPERATING ACTIVITIES   (1,089,011)   (2,320,426)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in intangibles   (44,405)   (544,320)
Investment in deposits   
-
    (12,792)
Deposit refunded   4,800    

-

 
Plant and equipment purchased   
-
    (40,500)
Investment in equity method investment   (1,000,000)   
-
 
Net cash used in investing activities – continuing operations   (1,039,605)   (597,612)
Net cash used in investing activities – discontinued operations   (36,230)   (41,320)
CASH USED IN INVESTING ACTIVITIES   (1,075,835)   (638,932)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from convertible notes   2,001,666    
-
 
Repayment of convertible notes   (189,326)   (1,147,063)
Repayment of federal relief loans   (2,864)   
-
 
Net cash provided by (used in) financing activities – continuing operations   1,809,476    (1,147,063)
Net cash provided by financing activities – discontinued operations   
-
    9,653 
NET CASH PROVIDED BY (SUED IN) FINANCING ACTIVITIES   1,809,476    (1,137,410)
           
NET DECREASE IN CASH   (355,370)   (4,096,768)
Cash and cash included in assets held for sale at the beginning of the period   374,765    5,449,751 
CASH AT END OF PERIOD  $19,395   $1,352,983 
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $373,822   $5,367,551 
Cash included in assets held for sale   943    82,200 
CASH AT THE BEGINNING OF THE PERIOD  $374,765   $5,449,751 
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $19,395   $1,348,702 
Cash included in assets held for sale   
-
    4,281 
CASH AT THE END OF THE PERIOD  $19,395   $1,352,983 
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $9,245   $88,260 
NON CASH INVESTING AND FINANCING ACTIVITIES          
Fair value of warrants issued with convertible notes  $819,834   $
-
 
Conversion of convertible debt to equity  $160,000   $
-
 
Fair value of warrants issued for equity method investments  $108,220   $
-
 

 

See notes to the unaudited condensed financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

b)Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with Open Path, Inc. (“Open Path”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with Open Path and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with Open Path and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and Open Path and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche is expected to be paid on or before November 30, 2023 (which may be subject to extension). Simultaneously with the funding of the initial Tranche, the Company issued to each of Open Path and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. The Company is still obligated to issue to each of open Path and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. The shares of Common Stock underlying the IPEX Warrant issued in connection with the funding of the initial Tranche will be pro-rated based on the amount of the initial Tranche. Simultaneously with the funding of the second and third Tranche, the Company will issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second and third Tranches. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

Frictionless Financial Technologies

 

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below (see note 5), the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express joint venture. See note 5 for further information.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three and nine months ended September 30, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) launching and scaling the IPSIPay Express products and the use by customers of such products, (ii) developing and implementing successful marketing campaigns and other strategic initiatives; (iii) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see notes 11 and 12); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

h)Reporting by Segment

 

No segmental information is required as the Company only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2023 and December 31, 2022.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $(28) and $0 for the three months ended September 30, 2023 and 2022, respectively and $410 and $0 for the nine months ended September 30, 2023 and 2022, respectively. 

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For the nine months ended September 30, 2023 and the year ended December 31, 2022, the Company had a net loss of $4,464,347 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the three and nine months ended September 30, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing, as well as potentially launching and deriving cash from IPEX during 2023 and into 2024. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis (including as required to meet its funding obligations to IPSIPay Express), the Company will be required to delay, reduce the scope of or terminate the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain cash flow positive and profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there currently is substantial doubt about their ability to continue as a going concern.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  

4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

The assets and liabilities disposed of as of May 12, 2023 were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 

 

5 NOVATION  OF CERTAIN ASSETS AND LIABILITES

 

On September 5, 2023, the Company entered into a novation agreement with a third party whereby the third party assumed all of the Company’s debts, clients, and services and assumes all the rights and responsibilities of the Company under the SAAS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (the “SAAS Agreement”), including the information technology, supplier access, billing and rating technology, mobile wallet, debit card enablement, back-office support services, customer service, and consulting services related to the Company’s IPSIPay mobile application.

 

Pursuant to the novation agreement, Frictionless released the Company from all its obligations, debts, and liabilities under the SAAS Agreement as of September 5, 2023 and consented to the third party assuming these obligations. Each party agreed to indemnify the other party harmless for any damages, claims or expenses incurred by the other party.

 

The novation agreement also provided the third party a 30-day transition period in which the Company assisted the third party in transferring all the assets and obligations, including existing customers and wallets to the third party, thereafter the third party will no longer be permitted to operate the IPSIPay app under the brand name “IPSIPay”.

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

5 NOVATION  OF CERTAIN ASSETS AND LIABILITES (continued)

 

The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:

 

   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 

 

6 DISCONTINUED OPERATIONS

 

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

 

The following assets and liabilities are reported as discontinued operations:

 

   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 

 

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

6 DISCONTINUED OPERATIONS (continued)

 

The statement of operations from discontinued operations is as follows:

 

   Three months
ended
   Three months
ended
   Six months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Revenue  $
        -
   $
-
   $
-
   $
-
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    15,618    40,821    59,962 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    15,618    40,821    59,962 
                     
Loss from operations before income taxes   
-
    (15,618)   (40,821)   (59,962)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $(15,618)  $(40,821)  $(59,962)

 

7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $41,320  and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).

 

    September 30,
2023
    December 31,
2022
 
    Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchased Technology - IPSIPay   $
-
    $
-
    $
-
    $ 1,401,491  
                                 

 

Amortization expense was $93,095 and $12,629 for the three months ended September 30, 2023 and 2022, respectively, and $347,298 and $12,629 for the nine months ended September 30, 2023 and 2022, respectively.

 

8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of September 30, 2023, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, The movement in equity method investments related to IPSIPay Express for the period ended September 30, 2023 is as follow:

 

   September 30,
2023
 
Cash contribution to IPSIPay Express  $1,000,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,108,220 
Equity loss from joint venture   (403,890)
   $704,330 

    

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

9 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

 

10 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Operating lease expense  $40,704   $43,200 

 

Other lease information:

 

   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(43,200)
           
Remaining lease term – operating lease   Monthly    Monthly 

 

11 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company.

 

The Company has repaid an aggregate principal amount of $2,864 and interest of $3,715 as of September 30, 2023. The loan balance outstanding as of September 30, 2023, consists of principal of $147,136 and accrued interest thereon of $14,432, of which $3,295 is disclosed as current.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “Cavalry/Mercer SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Cavalry/Mercer Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Cavalry/Mercer Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In connection with the December 30, 2022 Note Amendment Transaction, described in more detail in Note 13 below, the Original Cavalry/Mercer Warrants were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Cavalry/Mercer Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the Original Cavalry/Mercer Warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Notes payable to Cavalry and Mercer at September 30, 2023 consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   September 30,
2023
Amount, net
  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  December 30, 2023   482,000    36,685    518,685    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  December 30, 2023   482,000    36,686    518,686    482,134 
Total convertible notes payable          $964,000   $73,371   $1,037,371   $964,268 

  

Interest expense totaled $24,635 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $73,371 and $0 for the nine months ended September 30, 2023 and 2022, respectively.

 

16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Cavalry/Mercer Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 3,000,000 shares of Common Stock underlying the Extension Warrants was increased to 39,130,435 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

  

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and

 

(5)The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
    Maturity
date
   Principal   Accrued
Interest
   Unamortized
debt discount
   September 30,
2023
Amount, net
   December 31,
2022
Amount, net
 
Cavalry Fund I LP   10.00%    December 30, 2023    1,091,754    64,339    
-
    1,156,093    1,133,301 
                                     
Mercer Street Global 
Opportunity Fund, LLC
   10.00%    December 30, 2023    991,754    122,665    
-
    1,114,419    1,133,301 
                                     
Quick Capital, LLC   8.00%    December 20, 2023    62,857    1,405    (27,393)   36,869    
-
 
                                     
Red Road Holdings Corporation   17.13%    June 15, 2024    146,900    1,241    (137,354)   10,787    
-
 
                                     
2023 convertible notes   8.00 to 12.00%    December 31, 2023
to September 14, 2024
    1,676,666    41,270    (580,167)   1,137,769    
-
 
                                     
Total convertible notes payable             $3,969,931   $230,920   $(744,914)  $3,455,937   $2,266,602 

 

*These notes were repaid on August 3, 2023. See note 18.

 

Interest expense totaled $83,829 and $49,912 for the three months ended September 30, 2023 and 2022, respectively, and $212,886 and $138,085 for the nine months ended September 30, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $303,042 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $414,696 and $263,200 for the nine months ended September 30, 2023 and 2022, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

On August 24, 2023, Cavalry converted $60,000 of interest into 173,914 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $28,696

 

The balance of the Cavalry Note plus accrued interest at September 30, 2023 was $1,156,093.

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

On May 19, 2023, August 16, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

The balance of the Mercer Note plus accrued interest at September 30, 2023 was $1,114,419.

 

Quick Capital, LLC

 

On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 182,194 shares of Common Stock at an initial exercise price of $0.345 per share.

 

The balance of the Quick Capital Note plus accrued interest at September 30, 2023 was $36,870, net of unamortized debt discount of $27,393.

 

1800 Diagonal Street Lending LLC

 

On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

 

On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion. 

 

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, for $194,386, including the principal amount of $180,020, early settlement penalty of $9,306 and interest thereon of $5,060.

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

Red Road Holdings Corporation

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note, bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 17.13%, and maturing on June 15, 2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note plus accrued interest at September 30, 2023 was $10,787, net of unamortized debt discount of $137,354.

 

2023 Convertible Notes

 

Between February 13, 2023 and September 14, 2023, the Company entered into Securities Purchase Agreements with 24 accredited investors, pursuant to which the Company received an aggregate of $1,676,666 in gross proceeds in a private placement through the issuance of:

 

Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

 

five-year warrants (the “2023 Warrants”) to purchase an aggregate 4,682,093 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

The balance of the 2023 Notes plus accrued interest at September 30, 2023 was $1,137,769, net of unamortized debt discount of $580,167.

 

14 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 12 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model. These convertible notes were subsequently settled on August 3, 2023, resulting in the elimination of the derivative liability related to these notes.

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

14 DERIVATIVE LIABILITY (continued)

 

On September 12, 2023, the Company entered into a convertible note agreement with RRH which has variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $243,923 but limited to the cash value of the convertible notes of $125,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the three months ended September 30, 2023 was a net mark-to-market credit of $1,795,642 and for the nine months ended September 30, 2023 was a net market credit of $1,483,710, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

    Nine months
ended
September 30,
2023
    Year ended
December 31,
2022
 
Conversion price   $ 0.114 to $0.345     $ 0.345 to $4.50  
Risk free interest rate     3.60 to 5.55 %     0.79 to 4.73 %
Expected life of derivative liability     3.5 to 47 months       1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 217.01 %     120.49 to 258.3 %
Expected dividend rate     0 %     0 %

 

The movement in derivative liability is as follows:

 

   September 30,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   275,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,483,710)   (411,752)
   $1,341,932   $2,550,642 

 

15 STOCKHOLDERS’ EQUITY

 

a.Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 13,030,034 and 12,563,426 shares of Common Stock issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 13 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 13 above.

 

21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15 STOCKHOLDERS’ EQUITY (continued)

    

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    
-
    
-
    66,667    1.65 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding September 30, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at September 30, 2023 is as follows:

 

   Restricted Stock
Granted and
Vested
 
Grant date Price  Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47   683,167   $1.47 
$1.50   33,333    1.50 
$1.65   66,667    1.65 
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 and $172,766 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $298,298 for the nine months ended September 30, 2023 and 2022, respectively. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2023 and December 31, 2022.

 

22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15 STOCKHOLDERS’ EQUITY (continued)

    

d.Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 100,000 shares of Common Stock at an exercise price of $4.50 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $0.345 per share. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:

 

The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;

 

The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15 STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

    

Between February 13, 2023 and September 14, 2023, the Company entered into Securities Purchase Agreements with 124 accredited investors, as disclosed in note 13 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 4,682,093 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, Open Path and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of open Path and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of open Path and EfinityPay an additional IPEX warrant to purchase 166,667 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months
ended
September 30,
2023
 
Exercise price  $0.345 
Risk free interest rate   3.77 to 4.42 %
Expected life   5 years 
Expected volatility of underlying stock   187.40 to 190.77 %
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,475   $1.50 – 5.625   $3.60 
Granted   1,700,000    0.345 – 1.035    0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,374   $ 0.345 – 5.625   $0.9000 
Granted   4,982,096    0.3454.50    0.3605 
Forfeited   (33,333)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   9,135,137   $0.345 – 5.625   $0.6667 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

24

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15 STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

  

The warrants outstanding and exercisable at September 30, 2023 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    7,748,686    4.29         7,748,686         4.29 
$0.450    266,668    4.73         266,668         
4,73
 
$1.035    500,000    1.77         406,250         1.77 
$1.500    33,334    4.87         33,334         4.87 
$4.50    505,560    2.46         505,560         2.46 
$5.625    80,889    2.46         80,889         2.46 
      9,135,137    3.97   $0.6667    9,041,387   $0.6629    4.07 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 and $0 as of September 30, 2023 and 2022, respectively.

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667  shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 500,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $4.50 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 6,667 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 26,668 shares of Common Stock at an exercise price of $1.20 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

25

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15 STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

A summary of option activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,225    $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,893    $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   1,543,893    
$1.20 to 12.00
   $4.47 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at September 30, 2023 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    26,668    8.96         26,668         8.96 
$4.50    1,506,946    8.22         1,354,169         8.48 
$7.20    6,945    7.40         6,945         7.40 
$12.00    3,334    5.25         3,334         5.25 
      1,543,893    8.19   $4.47    1,391,116   $4.47    8.23 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2023 and 2022.

 

The option expense was $94,464 and $950,290 for the three months ended September 30, 2023 and 2022, respectively, and $283,392 and $1,139,220 for the nine months ended September 30, 2023 and 2022, respectively.

 

16 NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of shares of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three months and nine months ended September 30, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2023 and 2022 are as follows:

 

   Three and
nine months
ended
September 30,
2023
(Shares)
   Three and
nine months
ended
September 30,
2022
(Shares)
 
Convertible debt   13,046,469    491,290 
Stock options   1,543,893    1,543,893 
Warrants to purchase shares of Common Stock   9,135,137    1,943,472 
    23,725,499    3,978,655 

 

26

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

17 RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 500,000 shares of Common Stock at an exercise price of $4.50 per share.

 

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms.

 

The option expense for Mr. Corbett was $66,587 and $890,441 for the three months ended September 30, 2023 and 2022, respectively and $199,760 and $1,023,614 for the nine months ended September 30, 2023 and 2022, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

Madisson Butler

 

On September 13, 2022, the Company granted Ms. Butler (formerly known as Madisson Corbett), immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Butler was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

27

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

17 RELATED PARTY TRANSACTIONS (continued)

 

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022.

 

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 66,667 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $27,879 for each of the three months ended September 30, 2023 and 2022, and $83,636 for each of the nine months ended September 30, 2023 and 2022.

 

18 COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which mature between December 30, 2023 and September 14, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

 

19 SUBSEQUENT EVENTS

 

On October 19, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note, bearing interest at 13%, or $9,548, which interest is earned on issuance of the note and maturing on July 30,2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

On October 20, 2023, the Company entered into Securities Purchase Agreements with an accredited investor, pursuant to which the Company received an aggregate of $50,000 in gross proceeds in a private placement through the issuance of a Convertible Promissory Note and a five-year warrant to purchase an aggregate 144,928 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events. The convertible Promissory Note matures on October 20, 2024 and bears interest at 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

On November 1, 2023, the Company received an extension of the payment date of the third Tranche due under the IPSIPay Express Operating Agreement from October 31, 2023 to November 30, 2023.

 

On November 8, 2023, the Company received a notice of conversion from Cavalry, converting $100,000 of accrued interest into 289,855 shares of common stock at a conversion price of $0.345 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

28

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a provider of digital payment solutions and services to businesses and consumers.

 

Our historical core business was focused on operating and developing “e-wallets” that enabled consumers to deposit cash, convert it into a digital form, and remit the funds to Mexico and other countries quickly and securely. Our flagship e-wallet, IPSIPay®, was focused on the consumer market and was fully launched in July 2022 after a soft launch in December 2021.

 

The IPSIPay platform (which can be used both business-to-business and business-to-consumer) facilitated the transfer of funds in digital form to other countries, initially Mexico but also, India and the Philippines, primarily from hand-held devices as well as on desktop or laptop computers.

 

Our launch plan for IPSIPay was to target lower income, migrant communities in California (notably in the agriculture industry) and expanding to other states with large migrant populations such as Texas and Florida. We not only believed that the addressable market for IPSIPay was large and growing, but that servicing this market is socially responsible. Based on our public announcement in May 2023, described below, we exited the e-wallet line of business by novating all of our rights and obligations thereunder to a third party. We may in future develop another e-wallet product.

 

In May 2023, we publicly announced a new line of business called IPSIPay ExpressTM. This business is being operated via a three-way joint venture in the form of a Delaware limited liability company named IPSIPay Express, LLC (“IPSIPay Express”) between our company and payment industry veterans OpenPath, Inc. (“OpenPath”) and eFinityPay, LLC (“eFinityPay”). The purposes of IPSIPay Express is to develop and market a proprietary consumer to merchant real-time payment platform called Instant-Settlement in RealTime™ as well as to provide traditional credit card processing services initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, we entered into a Limited Liability Company Operating Agreement (the “IPEX Operating Agreement”) with OpenPath and EfinityPay, to provide for the terms of the IPSIPay Express joint venture. Pursuant to the IPEX Operating Agreement, The Company has agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company has made two tranches of capital contributions of $500,000 each, with a third tranche still to be made. With the full funding of each tranche, The Company currently owns 22.22% of the joint venture which percentage will increase to 33.33% on contribution of the third tranche of $500,000. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or shall be made by the following dates and in the following amounts: (i) $200,000 of the initial tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial tranche was paid on August 4, 2023; (iii) the second $500,000 tranche was paid during September 2023 and (iv) the third $500,000 tranche was to be paid by October 31, 2023 but is now expected to be paid on or before November 30, 2023.

 

Also, May 12, 2023, we entered into an agreement with one of our technology partners, Frictionless Financial Technologies, Inc. (“Frictionless”), to, among other things, divest ourselves of our interest in Frictionless and in Beyond Fintech, Inc., a joint venture entity we owned with Frictionless which has been developing an application called Beyond Wallet. See Note 1(b) to the accompanying financial statements for further information.

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

Launch and Scaling of E-Wallets; IPSIPay Express

 

IPSIPay

 

Having achieved full commercial integration and launch of the IPSIPay app during the third quarter of 2022, the key for our business was to scale the number of IPSIPay downloads achieved and revenue generated from transactions process by customers via IPSIPay.

 

29

 

 

We generated nominal IPSIPay-related revenue during the first half of 2023, with the initial goal of increasing revenues over time. In the current environment, it was taking longer than expected to win a customer’s trust and resulting fees generated by the usage of IPSIPay. Based on the slow growth rate in revenues, we elected to novate the Company’s rights and obligations to the IPSIPay platform and related e-wallet business to a third party who intends to invest and grow the business based on the existing platform and e-wallet. However, we retain the rights to develop e-wallets under the name “IPSIPay” in the future.

 

IPSIPay Express

 

While we believe the IPSIPay Express opportunity has great promise, as of the date of this report, IPEX has not been launched and we have derived no revenue or cash distributions from IPSIPay Express. No assurances can be given that IPSIPay Express will be successfully launched or will generate revenues or otherwise have a positive impact on our results of operations. We believe IPSIPay Express could be commercially launched and generate initial revenues in the fourth quarter of 2023, but no assurances can be provided that this will be achieved or that (i) we will be able to raise funds satisfactory to fulfill all of our capital contributions to IPSIPay Express or (ii) that we will ever receive distributions of free cash flow from IPSIPay Express. Moreover, the IPSIPay Express product offering will be targeting so-called “high risk” sectors such as online gaming and entertainment, which also carries certain risks.

 

Inflation

 

Macro-economic conditions could affect consumer spending adversely and consequently our future operations. The U.S experienced a period of significant inflation over the past several years, and while inflation has abated somewhat in the U.S., continuing high consumer prices and high interest rates arising from the Federal Reserve’s efforts to contain inflation could impact consumer’s desire to purchase goods and services utilizing our payment products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 

Foreign Exchange Risks

 

We intend to operate in several European countries. Changes and fluctuations in the foreign exchange rate between the US Dollar and the Euro, may in future have an effect our results of operations.

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

 

30

 

 

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

Conversion prices;

 

Current market prices of our equity

  

Risk free interest rates;

 

Expected remaining life of the derivative liability;

 

Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

 

Impairment of Investments and Intangible assets

 

The value of our intangibles were novated to a third party during the current quarter, prior to the novation, our intangible assets had not produced material revenues on which to assess whether the income generated from these assets could support the carrying value of these assets. For impairment testing of intangibles we determine the fair value of the underlying assets using an income-based approach which estimates the fair value using a discounted cash flow model. Key assumptions in estimating fair values include projected revenue growth and the weighted average cost of capital. Based on the novation of our remaining intangible asset to a third party, we no longer have indefinite lived intangible assets to consider for impairment.

 

Results of Operations

 

Results of Operations for the Three Months Ended September 30, 2023 and 2022

 

Net revenue

 

We recorded a minimal of revenues of $(28) during the three months ended September 30, 2023 and we did not have revenues during the three months ended September 30, 2022. We pivoted to focus our attention on the IPSIPay Express joint venture, we expect to generate initial revenues through the joint venture during the fourth quarter of 2023. We are focusing all of our efforts on developing and launching IPSIPay Express, which we believe has a higher possibility for revenue generation in both the near and long term.

 

Cost of goods sold

 

Cost of goods sold was $387 for the three months ended September 30, 2023 and consists primarily of bank and merchant related fees and chargebacks. We had no cost of goods sold, as we did not have revenues during the three months ended September 30, 2022.

 

31

 

 

General and administrative expenses

 

General and administrative expenses were $745,688 and $2,705,833 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $1,960,145 or 72.4%. The decrease primarily due to the following:

 

  (i) Selling and marketing costs were $87,361 and $412,567 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $325,206 or 78.8%. The decrease is primarily related to the fair value of immediately vesting warrants issued to Mario Lopez in the prior year valued at $289,654; the cessation of the social media campaign promoting the IPSIPay wallet, which in the prior year amounted to $21,934 and a reduction in marketing expenses of $19,899 which included the launch costs of the IPSIPay platform in September of the prior year. The Company has divested itself of the IPSIPay platform on September 5, 2023 and is concentrating its efforts on developing the IPSIPay Express business.
     
  (ii) Payroll expenses was $278,345 and $1,290,681 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $1,012,336 or 78.4%. The decrease is primarily attributable to the reduction in stock based compensation of $855,826 related to immediately vesting options issued to our CEO in the prior year and a reduction in restricted stock expense of $172,785 related to restricted stock issued to our CFO in the prior year and the amortization of vesting stock awards issued to our CEO in 2021.
     
  (iii) Consulting fees was $15,000 and $193,000 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $178,000 or 92.2%, The decrease is primarily due to immediately vesting restricted stock issued to two marketing consultants in the prior year amounting to $168,000 and additional consulting expenses amounting to $10,000 relating to the marketing consultants and certain once off IT consulting.
     
  (iv) Professional fees were $131,867 and $454,613 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $322,746 or 71.0%. The decrease is primarily due to the scaling back and subsequent cessation of the relationship with Frictionless during the current period, through the disposal of certain assets to Frictionless and the subsequent novation of the remaining IPSIPay assets to a third party as we focus all of our attention on the IPSIPay Express business opportunity.
     
  (v) The balance of the general and administrative expenses decreased by approximately $121,857 which is made up of several individually insignificant expenses.

  

Depreciation and amortization

 

Depreciation was $100,387 and $20,500 for the three months ended September 30, 2023 and 2022, respectively, an increase of $79,887, primarily due to the depreciation of the software platform which was subsequently novated to a third party on September 5, 2023.

 

Loss on debt conversion

 

Loss on debt conversion was $58,769 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $58,769 or 100%. The loss on debt conversion related to the conversion of $135,000 of convertible debt into 391,306 shares of common stock.

 

Penalty on convertible notes

 

Penalty on convertible notes was $9,306 and $602,100 for the three months ended September 30, 2023 and 2022, a decrease of $592,794 or 98.5%. The decrease is attributable to the prior year modification of the maturity date of two convertible notes, resulting in the negotiation of a 20% repayment penalty on the convertible notes and the value of the warrants to purchase 6,000,0000 shares of our Common Stock that were issued to the note holders as additional compensation for extending the maturity date of the convertible notes.

 

Loss on novation

 

Loss on novation was $1,066,165 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $1,066,165 or 100%. The loss on novation arose due the novation of the IPSIPay platform and all rights and obligations associated with the service agreement with Frictionless to a third party.

 

32

 

 

Fair value of warrants issued

 

Fair value of warrants issued was $14,176 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $14,176 or 100.0%. We issued a replacement warrant exercisable for 33,334 shares to an investor during the current period.

 

Interest expense, net

 

Interest expense was $110,328 and $51,340 for the three months ended September 30, 2023 and 2022, respectively, an increase of $58,988 or 114.9%. The increase is related to the additional $1,026,666 of convertible note funding raised during the current period to fund our investment in the IPSIPay Express joint venture which is expected to become operational in the fourth quarter of 2023.

 

Amortization of debt discount

 

Amortization of debt discount was $303,042 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $303,042 or 100.0%. The increase is primarily due to the amortization of debt discount related to the valuation of warrants, derivative liabilities and OID’s and fees paid on the $2,001,666 of convertible debt raised during the current year.

 

Derivative liability movements

 

Derivative liability movements were $1,795,642 and $84,895 for the three months ended September 30, 2023 and 2022, respectively, an increase of $1,710,747 or 2,015.1%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The credit during the current period represents the decrease in the mark-to-market value of the derivative liability due to a decrease in our stock price and the cash settlement of certain convertible notes which had derivative liability features.

 

Net loss from equity method investment

 

Net loss from equity method investment was $402,509 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $402,509 or 100.0%. On April 28, 2023, we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement with Open Path, Inc. and EfinityPay, LLC to memorialize the terms of our IPSIPay Express joint venture. The loss represents our proportionate share of the operating expenses of the joint venture and the additional loss associated with the increase in the basis of our investment from 11.11% to 22.22%, based on the net asset value of the joint venture.

 

Net loss from continuing operations

 

Net loss from continuing operations was $1,015,143 and $3,294,878 for the three months ended September 30, 2023 and 2022, respectively, a decrease in loss of $2,279,735 or 69.2%. The decrease is primarily due to the decrease in general and administrative expenses, the decrease in penalty on convertible notes and the derivative liability movements, offset by, the loss on novation , the increase in depreciation expenses and the amortization of debt discount, which are discussed in detail above.

 

Operating loss from discontinued operations

 

Operating loss from discontinued operations was $0 and $15,618 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $15,618 or 100.0%. Our Beyond fintech subsidiary was disposed of in the previous quarter.

 

Net loss

 

Net loss was $1,015,143 and $3,310,496 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $2,295,353 or 69.3%. The decrease is primarily attributable to the decrease in net loss from continuing operations, as discussed in detail above.

 

33

 

 

Results of Operations for the Nine Months Ended September 30, 2023 and September 30, 2022

 

Net revenue

 

We recorded minimal revenues of $410 during the nine months ended September 30, 2023 and we did not have revenues during the nine months ended September 30, 2022. We pivoted to focus our attention on the IPSIPay Express joint venture, we expect to generate initial revenues through the joint venture during the fourth quarter of 2023. We are focusing all of our efforts on developing and launching IPSIPay Express, which we believe has a higher possibility for revenue generation in the near and longer term.

 

Cost of goods sold

 

Cost of goods sold was $2,756 for the nine months ended September 30, 2023 and consists primarily of bank and merchant related fees and chargebacks. We had no cost of goods sold, as we did not have revenues during the nine months ended September 30, 2022.

 

General and administrative expenses

 

General and administrative expenses were $2,753,266 and $4,326,413 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $1,573,147 or 36.4%. The decrease is primarily due to the following:

 

  (i) Selling and marketing expenses were $348,003 and $498,494 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $150,491 or 30.2%. The decrease is primarily due to the fair value of the prior period immediately vesting warrants granted to Mario Lopez, offset by the monthly amortization of vesting warrants during the current period, and a reduction in both social media marketing and marketing expenses related to the launch of the IPSIPay platform and e-wallet in the prior year.
     
  (ii) Payroll expenses were $836,887 and $1,998,232 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $1,161,345 or  58.1%. The decrease is primarily attributable to the reduction in stock based compensation of $855,826 related to immediately vesting options issued to our CEO in the prior year and a reduction in restricted stock expense of $298,298 related to restricted stock issued to our CFO in the prior year and the amortization of vesting stock awards issued to our CEO in 2021.
     
  (iii) Legal fees were $611,178 and $335,846 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $275,332 or 82.0%. The increase is primarily due to the legal matters relating to unfair dismissal matters which were claimed in the prior year by several individuals.
     
  (iv) Professional fees were $583,873 and $734,300 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $150,427 or 20.5%. The decrease is due to the reduction in professional fees paid for social media management in the prior year.
     
  (v) Consulting fees was $85,000 and $247,900 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $162,900 or 65.7%. The decrease is primarily due to immediately vesting restricted stock issued to two marketing consultants in the prior year amounting to $168,000.
     
  (v) The balance of the general and administrative expenses decreased by approximately $223,316 which is made up of several individually insignificant expenses.

 

Depreciation

 

Depreciation was $380,092 and $29,493 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $350,599, primarily due to the depreciation of the software platform of $347,298 prior to its novation to a third party during the current period.

 

Loss on debt conversion

 

Loss on debt conversion was $77,247 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $77,247 or 100%. The loss on debt conversion related to the conversion of $160,000 of convertible debt into 463,770 shares of common stock.

 

34

 

 

Penalty on convertible notes

 

Penalty on convertible notes was $9,306 and $1,321,658 for the nine months ended September 30, 2023 and 2022, a decrease of $1,312,352 or 99.3%. The decrease is due to the repayment of one convertible note and the modification of the maturity date of two convertible notes during the prior year, resulting in the triggering of the repayment penalty per the convertible note agreements as well as additional penalties for the extension of the maturity date of convertible notes in the prior year.

 

Loss on novation

 

Loss on novation was $1,066,165 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $1,066,165 or 100%. The loss on novation arose due the novation of the IPSIPay platform and all rights and obligations associated with the service agreement with Frictionless to a third party.

 

Fair value of warrants issued

 

Fair value of warrants issued was $14,176 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $14,176 or 100.0%. We issued a replacement warrant exercisable for 33,334 shares to an investor during the current period.

 

Interest expense, net

 

Interest expense was $290,628 and $142,302 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $148,326 or 104.2%. The increase is related to the additional $2,001,666 of convertible note funding raised during the current year to fund the company’s investment in the IPSIPay Express joint venture which is expected to become operational in the second half of the year.

 

Amortization of debt discount

 

Amortization of debt discount was $414,696 and $263,200 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $151,496 or 57.6%. The increase is primarily due to the amortization of debt discount related to the valuation of warrants, derivative liabilities and OID’s and fees paid on the $2,001,666 of convertible debt raised during the current year.

 

Derivative liability movements

 

Derivative liability movements were $1,483,710 and $(65,046) for the nine months ended September 30, 2023 and 2022, respectively, a movement of $1,548,756 or 2,381.0%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the decrease in the mark-to-market value of the derivative liability due to a decrease in the share price and the increase in interest rates over the prior year.

 

Net loss from equity method investment

 

Net loss from equity method investment was $403,890 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $403,890 or 100.0%. On April 28, 2023, we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement with Open Path, Inc. and EfinityPay, LLC to memorialize the terms of our IPSIPay Express joint venture. The loss represents our proportionate share of the operating expenses of the joint venture and the additional loss associated with the increase in the basis of our investment from 11.11% to 22.22%, based on the net asset value of the joint venture.

 

Net loss from continuing operations

 

Net loss from continuing operations was $3,928,102 and $6,148,112 for the nine months ended September 30, 2023 and 2022, respectively, a decrease in loss of $2,220,010 or 36.1%. The decrease is primarily due to the decrease in general and administrative expenses, the decrease in the penalty on convertible notes and the movement in derivative liabilities, offset by, the loss on novation, the increase in interest expense and the increase in the amortization of debt discount, all discussed in detail above.

 

35

 

 

Operating loss from discontinued operations

 

Operating loss from discontinued operations was $40,821 and $59,962 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $19,141 or 31.9%. Beyond Fintech was disposed of in May 2023.

 

Loss on disposal of subsidiary

 

Loss on disposal of subsidiary was $495,424 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $495,424 or 100.0%. On May 12, 2023, the Company entered into an Agreement with Frictionless to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. The Company assigned to Frictionless all common stock of Frictionless owned by the Company and all shares of common stock of Beyond Fintech owned by the Company. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was $250,000, resulting in a net loss on disposal of $495,424.

 

Net loss

 

Net loss was $4,464,347 and $6,208,074 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $1,743,727 or 28.1%. the decrease is primarily attributable to the decrease in net loss from continuing operations and the loss on disposal of subsidiary and investment, as discussed in detail above.

 

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of $56,862,608 through September 30, 2023 and incurred negative cash flow from operations of $1,089,011 for the nine months ended September 30, 2023. Our primary focus was on launching and operating e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely, which will require us to spend, substantial amounts in connection with implementing our business strategy. During the second quarter we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement to memorialize the terms of the joint venture.

 

At September 30, 2023, we had cash of $19,395 and working capital deficit of $7,416,133 including a derivative liability of $1,341,932. After eliminating the derivative liability our working capital deficit is $6,074,201. Subsequent to September 30, 2023, between October 19, 2023 and October 20, we raised $110,000 through the issuance of convertible notes to accredited investors.

 

We used cash of $1,089,011 and $2,320,426 in operations for the nine months ended September 30, 2023 and 2022, respectively. Overall cash used in operations decreased by $1,231,415 due to cost containment efforts to preserve cash balances.

 

We invested a further $80,635 in our e-wallet platforms to enhance the product offering and to further develop the Beyond Wallet application (which was discontinued in May 2023). We also invested $1,000,000 in our IPSIPay Express joint venture to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

We generated cash of $1,809,476 during the current period primarily $2,001,666 from convertible notes issued to investors to bridge our working capital and repaid $189,326 of convertible notes. Cash utilized in financing activities for the nine months ended September 30, 2022 included the repayment of a convertible note of $1,147,063.

 

At September 30, 2023, we had outstanding convertible notes, including interest thereon of $4,200,851 (before unamortized debt discount of $744,915) and outstanding promissory notes, including interest thereon of $1,037,371. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rates of 8% to 17.3% per annum. and are convertible into our common stock at conversion prices ranging from fixed conversion prices of$0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), to variable conversion prices of 60% of lowest trading prices over a 20 trading day period. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

36

 

 

Pursuant to the IPSIPay Express joint venture agreement, we are required to invest another $500,000 in the JV by November 30, 2023, failing which our share of the joint venture will remain at 22.22%.

 

However, given our losses and negative cash flows, we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced or discontinued operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off balance sheet financing arrangements as of the date of this report.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of September 30, 2023 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

 

(b) Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended September 30, 2023.

 

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

37

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of our outstanding pending litigation matters. Litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business.

 

Voloshin v. Innovative Payment Solutions, Inc.

 

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees of our company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

 

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez; they appealed that decision. We moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion.

 

On May 25, 2022, the parties held a mediation in an attempt to resolve the matters. The mediation was unsuccessful.

 

On October 26, 2022, OSHA scheduled a hearing on Ms. Rey’s and Mr. Perez’s appeal for April 5, 2023. On November 8, 2022, the claimants’ counsel informed us that all five claimants intended to exercise their right to file a lawsuit in federal court and asked if we would stipulate to dismissal of Rey’s and Perez’s OSHA claims without prejudice. We agreed and a stipulation of dismissal without prejudice was filed on November 10, 2022.

 

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against IPSI and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, inter alia, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and IPSI. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802

 

Defendants moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings are stayed until the motion to compel arbitration is heard and decided. The hearing for the motion to compel arbitration was scheduled for May 4, 2023. The court held its ruling in abeyance to allow limited discovery and additional briefing. The court had issued a tentative ruling denying our motion to compel arbitration.  The court ordered plaintiffs to take their case to arbitration on August 30, 2023. Plaintiffs, however, have declined to file an arbitration and filed a petition for writ of mandate to challenge the order on October 27, 2023. The California Court of Appeals denied the petition on November 1, 2023.

 

Consequently, we filed a motion with the court for the appointment of an arbitrator and for the setting of a deadline for arbitration to be completed. The federal court declined to grant defendants IPSI and Williams Corbett (“defendants”) an extension of time until November 13 to file an answer and has ordered defendants and plaintiff to hold a meet and confer on the motion to stay.  Accordingly, defendants answered the complaint on October 27, 2023. Counsel are holding a meet and confer regarding the stay motion on November 15, 2023.   On the motion to stay the federal case until the arbitration in the state case occurs, defendants will argue that, because the parties and factual allegations in the arbitration and the federal case are exactly the same, the court should stay the federal case to allow the arbitration to be completed which will simplify the issues in the federal case or even resolve it completely.  

 

We anticipate filing the motion to stay on or about November 27.  The reasons are: a) court rules require us to wait five days after the meet and confer and to file a joint statement about the meet and confer before filing the motion; b) the motion must be noticed for a day within 35 days of filing the motion and the court hears motions on Mondays only; c) Monday Dec. 25, 2023 and Monday Jan. 1, 2024 are holidays.  Accordingly, the next date that the motion can be heard is January 8, 2024.

 

If the motion to stay is denied, defendants will file a motion for judgment on the pleadings.

 

We may engage in alternative dispute resolution with the plaintiffs but there can be no assurance that these efforts will be successful. While the outcome of the anticipated civil action is uncertain at this point, we intend to vigorously defend against the action.

 

38

 

 

Minkovich v. Corbett, et al.

 

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (I) breach of contract; (II) nonpayment of wages; (III) waiting time penalties; (IV) failure to indemnify for alleged employee business expenses; (V) violation of Section 17200 of the California Business and Professional Code; and (VI) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our company.

 

We are vigorously defending these claims, which are premised upon a putative three-year employment agreement that is not signed by our company or Mr. Corbett, and which Minkovich admits in his complaint that we expressly refused to sign.

 

We and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett have appealed that decision to the California Court of Appeal. As a result of the appeal, the court case is stayed until the appeal is decided, which we expect to take at least six months. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we and Mr. Corbett filed has yet to be decided and will not be decided unless the court’s decision is sustained on appeal. Otherwise, the case shall proceed to arbitration. We filed our opening brief on July 14, 2023, the case is in abeyance while we appeal our motion to compel arbitration. Plaintiffs obtained an extension and filed their answering brief in September 2023. Our reply brief is due on December 11, 2023.  

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

(a) Between July 18, 2023 and September 14, 2023, we entered into Securities Purchase Agreements with 13 accredited investors, pursuant to which we received an aggregate of $976,666 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

Convertible Notes Promissory (the “Notes” and each a “Note”); and

 

  five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 2,470,906 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature between 3.5 months and 12 months, and bear interest at rates from 8% to 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note, bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 17.13%, and maturing on June 15, 2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None. 

 

39

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
     
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

*Filed herewith

 

40

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
   
Date: November 13, 2023 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: November 13, 2023 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President & Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

41

 

 

0.08 0.26 0.31 0.50 0.00 0.00 0.00 0.04 0.08 0.26 0.35 0.50 12353866 12531868 12650758 12789493 P473Y false --12-31 Q3 0001591913 0001591913 2023-01-01 2023-09-30 0001591913 2023-11-13 0001591913 2023-09-30 0001591913 2022-12-31 0001591913 us-gaap:RelatedPartyMember 2023-09-30 0001591913 us-gaap:RelatedPartyMember 2022-12-31 0001591913 2023-07-01 2023-09-30 0001591913 2022-07-01 2022-09-30 0001591913 2022-01-01 2022-09-30 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001591913 2023-04-01 2023-06-30 0001591913 us-gaap:PreferredStockMember 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-06-30 0001591913 2023-06-30 0001591913 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001591913 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001591913 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001591913 us-gaap:PreferredStockMember 2023-09-30 0001591913 us-gaap:CommonStockMember 2023-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001591913 us-gaap:RetainedEarningsMember 2023-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-09-30 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001591913 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-06-30 0001591913 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001591913 us-gaap:PreferredStockMember 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-09-30 0001591913 2022-09-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2023-01-01 2023-09-30 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001591913 us-gaap:CommonStockMember 2019-11-01 0001591913 2019-11-01 0001591913 ipsi:ViviHoldingsIncMember 2019-12-31 2019-12-31 0001591913 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 srt:MaximumMember 2023-01-01 2023-09-30 0001591913 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-15 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-10-31 0001591913 us-gaap:WarrantMember 2023-09-30 0001591913 us-gaap:WarrantMember 2023-09-30 0001591913 srt:MinimumMember ipsi:CapitalContributionMember 2023-09-30 0001591913 srt:MaximumMember ipsi:CapitalContributionMember 2023-09-30 0001591913 ipsi:FrictionlessMember 2021-06-22 2021-06-22 0001591913 ipsi:FrictionlessMember 2023-09-30 0001591913 ipsi:FrictionlessMember 2023-01-01 2023-09-30 0001591913 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001591913 ipsi:BeyondFintechMember 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:BeyondFintechIncMember 2023-09-30 0001591913 ipsi:KiosksMember 2023-09-30 0001591913 us-gaap:ComputerEquipmentMember 2023-09-30 0001591913 us-gaap:OfficeEquipmentMember 2023-09-30 0001591913 2022-01-01 2022-12-31 0001591913 ipsi:OwnershipMember 2023-05-12 0001591913 2023-05-12 0001591913 ipsi:BeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-01-01 2023-05-12 0001591913 ipsi:NovationCertinAgreementMember 2023-09-30 0001591913 ipsi:NovationCertinAgreementMember 2023-01-01 2023-09-30 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2023-07-01 2023-09-30 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2022-07-01 2022-09-30 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2023-04-01 2023-09-30 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-09-30 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-08-26 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-09-30 0001591913 2021-01-01 2021-12-31 0001591913 ipsi:IPSIPayExpressMember 2023-01-01 2023-09-30 0001591913 2023-01-01 2023-01-01 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2023-09-30 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2023-01-01 2023-09-30 0001591913 ipsi:CavalryFundILPMember 2021-02-10 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 0001591913 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2022-12-30 0001591913 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 us-gaap:ConvertibleDebtMember 2023-09-30 0001591913 ipsi:AmendmentTransactionMember 2023-01-01 2023-09-30 0001591913 ipsi:CavalryFundILPMember 2023-09-30 0001591913 ipsi:CavalryFundILPMember 2023-01-01 2023-09-30 0001591913 ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 2022-02-01 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-01 2022-02-03 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2023-09-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2023-09-30 0001591913 2021-02-16 2021-02-16 0001591913 2022-01-01 2022-12-30 0001591913 ipsi:CavalryAndMercerMember 2022-01-01 2022-12-30 0001591913 2022-12-01 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 srt:MaximumMember ipsi:DebtInstrumentMember 2023-09-30 0001591913 srt:MinimumMember ipsi:DebtInstrumentMember 2023-09-30 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2023-08-01 2023-08-24 0001591913 ipsi:CavalryFundILPMember 2023-08-01 2023-08-24 0001591913 2023-08-01 2023-08-24 0001591913 ipsi:CavalryFundILPMember 2023-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 ipsi:MercerConvertedMember 2023-05-01 2023-05-19 0001591913 ipsi:MercerConvertedMember 2023-08-01 2023-08-16 0001591913 ipsi:MercerConvertedMember 2023-08-01 2023-08-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-09-30 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-09-30 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-01 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-10 0001591913 ipsi:CavalryAndMercerMember 2023-06-01 2023-06-13 0001591913 2023-06-01 2023-06-13 0001591913 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 2023-08-03 0001591913 us-gaap:ConvertibleDebtMember ipsi:DiagonalStreetLendingLLCMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-01 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-06-15 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-09-30 0001591913 2023-09-14 0001591913 srt:MinimumMember 2023-09-30 0001591913 srt:MaximumMember 2023-09-30 0001591913 ipsi:DebtInstrumentMember 2023-09-30 0001591913 ipsi:QuickCapitalLLCMember 2023-09-30 0001591913 ipsi:QuickCapitalLLCMember 2023-01-01 2023-09-30 0001591913 ipsi:QuickCapitalLLCMember 2022-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-30 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-01-01 2023-09-30 0001591913 ipsi:RedRoadHoldingsCorporationMember 2022-12-31 0001591913 srt:MinimumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-09-30 0001591913 srt:MaximumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-01-01 2023-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2022-12-31 0001591913 2023-05-10 0001591913 2023-09-12 0001591913 ipsi:BlackScholesMember 2023-09-12 0001591913 srt:MinimumMember 2023-01-01 2023-09-30 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 2023-05-19 2023-05-19 0001591913 2023-08-01 2023-08-16 0001591913 srt:MinimumMember us-gaap:CommonStockMember 2023-08-01 2023-08-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-08-01 2023-08-30 0001591913 2023-08-01 2023-08-30 0001591913 2023-08-01 2023-08-31 0001591913 srt:MinimumMember 2023-08-01 2023-08-31 0001591913 srt:MaximumMember 2023-08-01 2023-08-31 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 us-gaap:CommonStockMember 2022-08-01 2022-08-30 0001591913 2022-08-01 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-30 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 ipsi:DebtConversionNoticesMember 2023-01-01 2023-09-30 0001591913 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-09-30 0001591913 srt:MaximumMember 2023-09-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-09-30 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2021-10-22 0001591913 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-01 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-01 2022-09-13 0001591913 2022-09-13 0001591913 ipsi:TotalRestrictedSharesMember 2021-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-09-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-09-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-09-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-09-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-09-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-09-30 0001591913 ipsi:TotalRestrictedSharesMember 2023-09-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-09-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-09-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-09-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-09-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-09-30 0001591913 ipsi:ExercisePrice0049Member 2023-01-01 2023-09-30 0001591913 ipsi:ExercisePriceRange5Member 2023-01-01 2023-09-30 0001591913 ipsi:ExercisePrice0055Member 2023-01-01 2023-09-30 0001591913 ipsi:WarrantsMember 2023-09-30 0001591913 srt:MinimumMember ipsi:WarrantsMember 2023-01-01 2023-09-30 0001591913 srt:MaximumMember ipsi:WarrantsMember 2023-01-01 2023-09-30 0001591913 ipsi:WarrantsMember 2023-01-01 2023-09-30 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice00115Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice00115Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice00115Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice00115Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice00345Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice00345Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice00345Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice00345Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice0015Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice0015Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice0015Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice0015Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice1500Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice1500Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice1500Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice1500Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice0187Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice0187Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice0187Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice0187Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice5625Member 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember ipsi:ExercisePrice5625Member 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice5625Member 2023-09-30 0001591913 ipsi:WarrantsExercisableMember ipsi:ExercisePrice5625Member 2023-01-01 2023-06-30 0001591913 ipsi:WarrantsOutstandingMember 2023-09-30 0001591913 ipsi:WarrantsOutstandingMember 2022-10-01 2023-09-30 0001591913 ipsi:WarrantsExercisableMember 2023-09-30 0001591913 ipsi:WarrantsExercisableMember 2023-01-01 2023-06-30 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001591913 us-gaap:StockOptionMember 2023-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice004Member 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice004Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember ipsi:ExercisePrice004Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice015Member 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice015Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember ipsi:ExercisePrice015Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice024Member 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice024Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember ipsi:ExercisePrice024Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice040Member 2023-09-30 0001591913 ipsi:OptionsOutstandingMember ipsi:ExercisePrice040Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember ipsi:ExercisePrice040Member 2023-01-01 2023-09-30 0001591913 ipsi:OptionsOutstandingMember 2023-09-30 0001591913 ipsi:OptionsOutstandingMember 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember 2023-01-01 2023-09-30 0001591913 ipsi:OptionsExercisableMember 2023-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-07-01 2023-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-07-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001591913 ipsi:StockOptionsMember 2023-07-01 2023-09-30 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-09-30 0001591913 ipsi:StockOptionsMember 2022-07-01 2022-09-30 0001591913 ipsi:StockOptionsMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001591913 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001591913 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 ipsi:MrFullerMember 2022-09-13 2022-09-13 0001591913 ipsi:MrFullerMember 2022-09-01 2022-09-13 0001591913 ipsi:MrFullerMember 2023-07-01 2023-09-30 0001591913 ipsi:MrFullerMember 2022-07-01 2022-09-30 0001591913 ipsi:MrFullerMember 2023-01-01 2023-09-30 0001591913 ipsi:MrFullerMember 2022-01-01 2022-09-30 0001591913 ipsi:WilliamCorbettMember 2022-07-11 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2023-06-21 0001591913 ipsi:WilliamCorbettMember 2023-07-01 2023-09-30 0001591913 ipsi:WilliamCorbettMember 2022-07-01 2022-09-30 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-09-30 0001591913 ipsi:WilliamCorbettMember 2022-01-01 2022-09-30 0001591913 ipsi:CliffordHenryMember 2023-01-01 2023-09-30 0001591913 ipsi:CliffordHenryMember 2022-09-13 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-09-13 0001591913 ipsi:CliffordHenryMember 2023-07-01 2023-09-30 0001591913 ipsi:CliffordHenryMember 2022-07-01 2022-09-30 0001591913 ipsi:CliffordHenryMember 2022-01-01 2022-09-30 0001591913 ipsi:MadissonCorbettMember 2022-09-13 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2023-07-01 2023-09-30 0001591913 ipsi:MadissonCorbettMember 2022-07-01 2022-09-30 0001591913 ipsi:MadissonCorbettMember 2023-01-01 2023-09-30 0001591913 ipsi:MadissonCorbettMember 2022-01-01 2022-09-30 0001591913 ipsi:DavidRiosMember 2022-09-13 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-01 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-13 0001591913 ipsi:DavidRiosMember 2023-07-01 2023-09-30 0001591913 ipsi:DavidRiosMember 2022-07-01 2022-09-30 0001591913 ipsi:DavidRiosMember 2023-01-01 2023-09-30 0001591913 ipsi:DavidRiosMember 2022-01-01 2022-09-30 0001591913 ipsi:MrRosenblumMember 2022-07-01 2022-07-11 0001591913 ipsi:MrRosenblumMember 2022-07-11 0001591913 ipsi:MrRosenblumMember 2023-07-01 2023-09-30 0001591913 ipsi:MrRosenblumMember 2022-07-01 2022-09-30 0001591913 ipsi:MrRosenblumMember 2023-01-01 2023-09-30 0001591913 ipsi:MrRosenblumMember 2022-01-01 2022-09-30 0001591913 us-gaap:SubsequentEventMember 2023-10-19 0001591913 us-gaap:SubsequentEventMember 2023-10-19 2023-10-19 0001591913 us-gaap:SubsequentEventMember 2023-10-20 0001591913 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-10-20 2023-10-20 0001591913 us-gaap:SubsequentEventMember us-gaap:WarrantMember 2023-10-20 0001591913 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-10-20 2023-10-20 0001591913 srt:ScenarioForecastMember 2023-11-08 0001591913 srt:ScenarioForecastMember 2023-11-08 2023-11-08 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William Corbett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023 /s/ William Corbett
  William Corbett
  Chief Executive Officer
  (Principal Executive Officer)

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023 /s/ Richard Rosenblum
  Richard Rosenblum
  President and Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 13, 2023 By: /s/ William Corbett
    William Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 13, 2023 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 13, 2023
Document Information Line Items    
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   13,319,889
Amendment Flag false  
Entity Central Index Key 0001591913  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55648  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 33-1230229  
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
City Area Code (866)  
Local Phone Number 477-4729  
Entity Interactive Data Current Yes  
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 19,395 $ 373,822
Other current assets 49,414 97,042
Assets held for sale 807,263
Total Current Assets 68,809 1,278,127
Non-current assets    
Plant and equipment 7,569 40,362
Intangible assets 1,401,491
Security deposit 15,000 32,592
Equity method investment 704,330
Total Non-Current Assets 726,899 1,474,445
Total Assets 795,708 2,752,572
Current Liabilities    
Accounts payable 1,596,407 727,922
Liabilities held for sale 33,810
Federal relief loans – current portion 3,295
Notes payable 1,037,371 964,268
Convertible debt, net of unamortized discount of $744,914 and $0, respectively 3,455,937 2,266,602
Derivative liability 1,341,932 2,550,642
Total Current Liabilities 7,484,942 6,543,244
Non-Current Liabilities    
Federal relief loans 158,273 163,978
Total Non-Current Liabilities 158,273 163,978
Total Liabilities 7,643,215 6,707,222
Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,030,034 and 12,563,426 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively. [1] 1,303 1,256
Additional paid-in-capital [1] 50,013,798 48,442,355
Accumulated deficit (56,862,608) (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders (6,847,507) (3,956,247)
Non-controlling interest 1,597
Total Equity (Deficit) [2] (6,847,507) (3,954,650)
Total Liabilities and Equity (Deficit) 795,708 2,752,572
Related Party [Member]    
Current Liabilities    
Related party payables $ 50,000
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
[2] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 744,914 $ 0
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares issued 13,030,034 12,563,426
Common stock, shares outstanding 13,030,034 12,563,426
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net Revenue $ (28) $ 410
Cost of Goods Sold 387 2,756
Gross loss (415) (2,346)
General and administrative 745,688 2,705,833 2,753,266 4,326,413
Depreciation and amortization 100,387 20,500 380,092 29,493
Total Expense 846,075 2,726,333 3,133,358 4,355,906
Loss from Operations (846,490) (2,726,333) (3,135,704) (4,355,906)
Loss on debt conversion (58,769) (77,247)
Penalty on convertible notes (9,306) (602,100) (9,306) (1,321,658)
Loss on novation (1,066,165)   (1,066,165)
Fair value of warrants issued (14,176)   (14,176)  
Interest expense (110,328) (51,340) (290,628) (142,302)
Amortization of debt discount (303,042) (414,696) (263,200)
Derivative liability movements 1,795,642 84,895 1,483,710 (65,046)
Loss before Income Taxes (612,634) (3,294,878) (3,524,212) (6,148,112)
Income Taxes
Net Loss after income taxes (612,634) (3,294,878) (3,524,212) (6,148,112)
Net loss from equity method investments (402,509) (403,890)
Net loss from continuing operations (1,015,143) (3,294,878) (3,928,102) (6,148,112)
Discontinued operations        
Operating loss from discontinued operations (15,618) (40,821) (59,962)
Loss on disposal of subsidiary and investment (495,424)
Discontinued operations (15,618) (536,245) (59,962)
Net loss (1,015,143) [1] (3,310,496) [1] (4,464,347) (6,208,074)
Net loss attributable to non-controlling interest 7,652 1,597 29,381
Net loss attributable to Innovative Payment Solutions, Inc., stockholders $ (1,015,143) $ (3,302,844) $ (4,462,750) $ (6,178,693)
Basic and diluted loss per share*        
Continuing operations (in Dollars per share) [2] $ (0.08) $ (0.26) $ (0.31) $ (0.5)
Discontinued operations (in Dollars per share) [2] 0 0 (0.04) 0
Basic and diluted loss per share total (in Dollars per share) $ (0.08) $ (0.26) $ (0.35) $ (0.5)
Weighted Average Number of Shares Outstanding – Basic (in Shares) [2] 12,789,493 12,531,868 12,650,758 12,353,866
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
[2] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Continuing operations diluted [1] $ (0.08) $ (0.26) $ (0.31) $ (0.50)
Discontinued operations diluted [1] 0.00 0.00 (0.04) 0.00
Diluted loss per share $ (0.08) $ (0.26) $ (0.35) $ (0.50)
Weighted Average Number of Shares Outstanding – Diluted (in Shares) [1] 12,789,493 12,531,868 12,650,758 12,353,866
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2021 $ 1,226 [1] $ 45,806,576 [1] $ (42,111,701) $ 35,211 $ 3,731,312 [1]
Balance (in Shares) at Dec. 31, 2021 12,263,426 [1]        
Stock based option expense 94,466 [1] 94,466 [1]
Restricted stock awards 62,766 [1] 62,766 [1]
Net loss (1,801,494) (8,752) (1,810,246) [1]
Balance at Mar. 31, 2022 $ 1,226 [1] 45,963,808 [1] (43,913,195) 26,459 2,078,298 [1]
Balance (in Shares) at Mar. 31, 2022 12,263,426 [1]        
Balance at Dec. 31, 2021 $ 1,226 [1] 45,806,576 [1] (42,111,701) 35,211 3,731,312 [1]
Balance (in Shares) at Dec. 31, 2021 12,263,426 [1]        
Net loss           (6,208,074)
Balance at Sep. 30, 2022 $ 1,256 [1] 47,899,980 [1] (48,290,394) 15,483 373,675 [1]
Balance (in Shares) at Sep. 30, 2022 12,563,426 [1]        
Balance at Dec. 31, 2021 $ 1,226 [1] 45,806,576 [1] (42,111,701) 35,211 3,731,312 [1]
Balance (in Shares) at Dec. 31, 2021 12,263,426 [1]        
Net loss           (10,331,424)
Balance at Dec. 31, 2022 $ 1,256 [1] 48,442,355 [1] (52,399,858) 1,597 (3,954,650) [1]
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Balance at Mar. 31, 2022 $ 1,226 [1] 45,963,808 [1] (43,913,195) 26,459 2,078,298 [1]
Balance (in Shares) at Mar. 31, 2022 12,263,426 [1]        
Contribution by minority shareholders 9,653 9,653 [1]
Stock based option expense 94,462 [1] 94,462 [1]
Restricted stock awards 62,766 [1] 62,766 [1]
Net loss (1,074,355) (12,977) (1,087,332) [1]
Balance at Jun. 30, 2022 $ 1,226 [1] 46,121,036 [1] (44,987,550) 23,135 1,157,847 [1]
Balance (in Shares) at Jun. 30, 2022 12,263,426 [1]        
Fair value of warrants issued 322,918 [1] 322,918 [1]
Shares issued for services [1] $ 23 [1] 332,977 [1] 333,000 [1]
Shares issued for services (in Shares) 233,333 [1]        
Stock based option expense 1,013,056 [1] 1,013,056 [1]
Restricted stock awards [1] $ 7 [1] 109,993 [1] 110,000 [1]
Restricted stock awards (in Shares) 66,667 [1]        
Net loss (3,302,844) (7,652) (3,310,496) [1]
Balance at Sep. 30, 2022 $ 1,256 [1] 47,899,980 [1] (48,290,394) 15,483 373,675 [1]
Balance (in Shares) at Sep. 30, 2022 12,563,426 [1]        
Balance at Dec. 31, 2022 $ 1,256 [1] 48,442,355 [1] (52,399,858) 1,597 (3,954,650) [1]
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Fair value of warrants issued to convertible debt holders 251,856 [1] 251,856 [1]
Stock based compensation 130,671 [1] 130,671 [1]
Net loss (273,390) (1,597) (274,987) [1]
Balance at Mar. 31, 2023 $ 1,256 [1] 48,824,882 [1] (52,673,248) (3,847,110) [1]
Balance (in Shares) at Mar. 31, 2023 12,563,426 [1]        
Balance at Dec. 31, 2022 $ 1,256 [1] 48,442,355 [1] (52,399,858) 1,597 (3,954,650) [1]
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Fair value of warrants issued           920,392
Net loss           (4,464,347)
Balance at Sep. 30, 2023 $ 1,303 [1] 50,013,798 [1] (56,862,608) (6,847,507) [1]
Balance (in Shares) at Sep. 30, 2023 13,030,034 [1]        
Balance at Mar. 31, 2023 $ 1,256 [1] 48,824,882 [1] (52,673,248) (3,847,110) [1]
Balance (in Shares) at Mar. 31, 2023 12,563,426 [1]        
Conversion of convertible debt $ 7 [1] 43,471 [1] 43,478 [1]
Conversion of convertible debt (in Shares) 72,464 [1]        
Fair value of warrants issued to convertible debt holders 130,025 [1] 130,025 [1]
Fair value of warrants issued for equity method investments 108,220 [1] 108,220 [1]
Stock based compensation 130,671 [1] 130,671 [1]
Net loss (3,174,217) (3,174,217) [1]
Balance at Jun. 30, 2023 $ 1,263 [1] 49,237,269 [1] (55,847,465) (6,608,933) [1]
Balance (in Shares) at Jun. 30, 2023 12,635,890 [1]        
Conversion of convertible debt $ 40 [1] 193,729 [1] 193,769 [1]
Conversion of convertible debt (in Shares) 391,306 [1]        
Additional shares issued on reverse stock split (in Shares) 2,838 [1]        
Fair value of warrants issued 14,176 [1] 14,176 [1]
Fair value of warrants issued to convertible debt holders 437,953 [1] 437,953 [1]
Stock based compensation 130,671 [1] 130,671 [1]
Net loss (1,015,143) (1,015,143) [1]
Balance at Sep. 30, 2023 $ 1,303 [1] $ 50,013,798 [1] $ (56,862,608) $ (6,847,507) [1]
Balance (in Shares) at Sep. 30, 2023 13,030,034 [1]        
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (1,015,143) [1] $ (274,987) [1] $ (3,310,496) [1] $ (1,810,246) [1] $ (4,464,347) $ (6,208,074) $ (10,331,424)
Net loss from discontinued operations   15,618   536,245 59,962  
Net loss from continuing operations         (3,928,102) (6,148,112)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Derivative liability movements         (1,483,710) 65,046  
Depreciation 100,387   20,500   380,092 29,493  
Amortization of debt discount 303,042     414,696 263,200  
Loss on novation 1,066,165       1,066,165  
Loss on conversion of debt to equity 58,769     77,247  
Penalty on convertible debt 9,306   602,100   9,306 1,321,658  
Unrealized loss on equity method investments         403,890  
Shares issued for services         333,000  
Stock based compensation         283,392 1,437,516  
Fair value of warrants issued         122,797 322,918  
Changes in Assets and Liabilities              
Other current assets         47,628 (48,846)  
Accounts payable and accrued expenses         1,150,919 126,111  
Related party payables         50,000  
Interest accruals         281,383 54,042  
Cash used in operating activities – continuing operations         (1,124,297) (2,243,974)  
Cash provided by (used in) operating activities – discontinued operations         35,286 (76,452)  
CASH USED IN OPERATING ACTIVITIES         (1,089,011) (2,320,426)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Investment in intangibles         (44,405) (544,320)  
Investment in deposits         (12,792)  
Deposit refunded         4,800  
Plant and equipment purchased         (40,500)  
Investment in equity method investment         (1,000,000)  
Net cash used in investing activities – continuing operations         (1,039,605) (597,612)  
Net cash used in investing activities – discontinued operations         (36,230) (41,320)  
CASH USED IN INVESTING ACTIVITIES         (1,075,835) (638,932)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from convertible notes         2,001,666  
Repayment of convertible notes         (189,326) (1,147,063)  
Repayment of federal relief loans         (2,864)  
Net cash provided by (used in) financing activities – continuing operations         1,809,476 (1,147,063)  
Net cash provided by financing activities – discontinued operations         9,653  
NET CASH PROVIDED BY (SUED IN) FINANCING ACTIVITIES         1,809,476 (1,137,410)  
NET DECREASE IN CASH         (355,370) (4,096,768)  
Cash and cash included in assets held for sale at the beginning of the period   374,765   5,449,751 374,765 5,449,751 5,449,751
CASH AT END OF PERIOD 19,395   1,352,983   19,395 1,352,983 374,765
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS              
Cash   373,822   5,367,551 373,822 5,367,551 5,367,551
Cash included in assets held for sale   943   82,200 943 82,200 82,200
CASH AT THE BEGINNING OF THE PERIOD   $ 374,765   $ 5,449,751 374,765 5,449,751 5,449,751
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS              
Cash 19,395   1,348,702   19,395 1,348,702 373,822
Cash included in assets held for sale   4,281   4,281 943
CASH AT THE END OF THE PERIOD $ 19,395   $ 1,352,983   19,395 1,352,983 $ 374,765
CASH PAID FOR INTEREST AND TAXES:              
Cash paid for income taxes          
Cash paid for interest         9,245 88,260  
NON CASH INVESTING AND FINANCING ACTIVITIES              
Fair value of warrants issued with convertible notes         819,834  
Conversion of convertible debt to equity         160,000  
Fair value of warrants issued for equity method investments         $ 108,220  
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Organization and Description of Business
9 Months Ended
Sep. 30, 2023
Organization and Description of Business [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

b)Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with Open Path, Inc. (“Open Path”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with Open Path and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with Open Path and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and Open Path and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche is expected to be paid on or before November 30, 2023 (which may be subject to extension). Simultaneously with the funding of the initial Tranche, the Company issued to each of Open Path and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. The Company is still obligated to issue to each of open Path and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. The shares of Common Stock underlying the IPEX Warrant issued in connection with the funding of the initial Tranche will be pro-rated based on the amount of the initial Tranche. Simultaneously with the funding of the second and third Tranche, the Company will issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second and third Tranches. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

Frictionless Financial Technologies

 

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below (see note 5), the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express joint venture. See note 5 for further information.

v3.23.3
Accounting Policies and Estimates
9 Months Ended
Sep. 30, 2023
Accounting Policies and Estimates [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three and nine months ended September 30, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) launching and scaling the IPSIPay Express products and the use by customers of such products, (ii) developing and implementing successful marketing campaigns and other strategic initiatives; (iii) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see notes 11 and 12); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

h)Reporting by Segment

 

No segmental information is required as the Company only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2023 and December 31, 2022.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $(28) and $0 for the three months ended September 30, 2023 and 2022, respectively and $410 and $0 for the nine months ended September 30, 2023 and 2022, respectively. 

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

v3.23.3
Liquidity Matters and Going Concern
9 Months Ended
Sep. 30, 2023
Liquidity Matters and Going Concern [Abstract]  
LIQUIDITY MATTERS AND GOING CONCERN
3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For the nine months ended September 30, 2023 and the year ended December 31, 2022, the Company had a net loss of $4,464,347 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the three and nine months ended September 30, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing, as well as potentially launching and deriving cash from IPEX during 2023 and into 2024. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis (including as required to meet its funding obligations to IPSIPay Express), the Company will be required to delay, reduce the scope of or terminate the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain cash flow positive and profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there currently is substantial doubt about their ability to continue as a going concern.

v3.23.3
Disposal of Investment in Frictionless and Beyond Fintech
9 Months Ended
Sep. 30, 2023
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH
4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

The assets and liabilities disposed of as of May 12, 2023 were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
v3.23.3
Novation of Certain Assets and Liabilites
9 Months Ended
Sep. 30, 2023
Novation of Certain Assets and Liabilites [Abstract]  
NOVATION OF CERTAIN ASSETS AND LIABILITES
5 NOVATION  OF CERTAIN ASSETS AND LIABILITES

 

On September 5, 2023, the Company entered into a novation agreement with a third party whereby the third party assumed all of the Company’s debts, clients, and services and assumes all the rights and responsibilities of the Company under the SAAS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (the “SAAS Agreement”), including the information technology, supplier access, billing and rating technology, mobile wallet, debit card enablement, back-office support services, customer service, and consulting services related to the Company’s IPSIPay mobile application.

 

Pursuant to the novation agreement, Frictionless released the Company from all its obligations, debts, and liabilities under the SAAS Agreement as of September 5, 2023 and consented to the third party assuming these obligations. Each party agreed to indemnify the other party harmless for any damages, claims or expenses incurred by the other party.

 

The novation agreement also provided the third party a 30-day transition period in which the Company assisted the third party in transferring all the assets and obligations, including existing customers and wallets to the third party, thereafter the third party will no longer be permitted to operate the IPSIPay app under the brand name “IPSIPay”.

 

The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:

 

   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 
v3.23.3
Discontinued Operations
9 Months Ended
Sep. 30, 2023
Discontinued Operations [Abstract]  
DISCONTINUED OPERATIONS
6 DISCONTINUED OPERATIONS

 

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

 

The following assets and liabilities are reported as discontinued operations:

 

   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 

 

The statement of operations from discontinued operations is as follows:

 

   Three months
ended
   Three months
ended
   Six months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Revenue  $
        -
   $
-
   $
-
   $
-
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    15,618    40,821    59,962 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    15,618    40,821    59,962 
                     
Loss from operations before income taxes   
-
    (15,618)   (40,821)   (59,962)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $(15,618)  $(40,821)  $(59,962)
v3.23.3
Intangibles
9 Months Ended
Sep. 30, 2023
Intangibles [Abstract]  
INTANGIBLES
7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $41,320  and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).

 

    September 30,
2023
    December 31,
2022
 
    Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchased Technology - IPSIPay   $
-
    $
-
    $
-
    $ 1,401,491  
                                 

 

Amortization expense was $93,095 and $12,629 for the three months ended September 30, 2023 and 2022, respectively, and $347,298 and $12,629 for the nine months ended September 30, 2023 and 2022, respectively.

v3.23.3
Equity Method Investment
9 Months Ended
Sep. 30, 2023
Equity Method Investment [Abstract]  
EQUITY METHOD INVESTMENT
8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of September 30, 2023, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, The movement in equity method investments related to IPSIPay Express for the period ended September 30, 2023 is as follow:

 

   September 30,
2023
 
Cash contribution to IPSIPay Express  $1,000,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,108,220 
Equity loss from joint venture   (403,890)
   $704,330 
v3.23.3
Investments
9 Months Ended
Sep. 30, 2023
Investments [Abstract]  
INVESTMENTS
9 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
LEASES
10 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Operating lease expense  $40,704   $43,200 

 

Other lease information:

 

   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(43,200)
           
Remaining lease term – operating lease   Monthly    Monthly 
v3.23.3
Federal Relief Loans
9 Months Ended
Sep. 30, 2023
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
11 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company.

 

The Company has repaid an aggregate principal amount of $2,864 and interest of $3,715 as of September 30, 2023. The loan balance outstanding as of September 30, 2023, consists of principal of $147,136 and accrued interest thereon of $14,432, of which $3,295 is disclosed as current.

v3.23.3
Notes Payable
9 Months Ended
Sep. 30, 2023
Notes Payable [Abstract]  
NOTES PAYABLE
12 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “Cavalry/Mercer SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Cavalry/Mercer Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Cavalry/Mercer Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In connection with the December 30, 2022 Note Amendment Transaction, described in more detail in Note 13 below, the Original Cavalry/Mercer Warrants were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Cavalry/Mercer Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the Original Cavalry/Mercer Warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Notes payable to Cavalry and Mercer at September 30, 2023 consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   September 30,
2023
Amount, net
  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  December 30, 2023   482,000    36,685    518,685    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  December 30, 2023   482,000    36,686    518,686    482,134 
Total convertible notes payable          $964,000   $73,371   $1,037,371   $964,268 

  

Interest expense totaled $24,635 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $73,371 and $0 for the nine months ended September 30, 2023 and 2022, respectively.

v3.23.3
Convertible Notes Payable
9 Months Ended
Sep. 30, 2023
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
13 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of Common Stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Cavalry/Mercer Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 3,000,000 shares of Common Stock underlying the Extension Warrants was increased to 39,130,435 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

  

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and

 

(5)The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
    Maturity
date
   Principal   Accrued
Interest
   Unamortized
debt discount
   September 30,
2023
Amount, net
   December 31,
2022
Amount, net
 
Cavalry Fund I LP   10.00%    December 30, 2023    1,091,754    64,339    
-
    1,156,093    1,133,301 
                                     
Mercer Street Global 
Opportunity Fund, LLC
   10.00%    December 30, 2023    991,754    122,665    
-
    1,114,419    1,133,301 
                                     
Quick Capital, LLC   8.00%    December 20, 2023    62,857    1,405    (27,393)   36,869    
-
 
                                     
Red Road Holdings Corporation   17.13%    June 15, 2024    146,900    1,241    (137,354)   10,787    
-
 
                                     
2023 convertible notes   8.00 to 12.00%    December 31, 2023
to September 14, 2024
    1,676,666    41,270    (580,167)   1,137,769    
-
 
                                     
Total convertible notes payable             $3,969,931   $230,920   $(744,914)  $3,455,937   $2,266,602 

 

*These notes were repaid on August 3, 2023. See note 18.

 

Interest expense totaled $83,829 and $49,912 for the three months ended September 30, 2023 and 2022, respectively, and $212,886 and $138,085 for the nine months ended September 30, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $303,042 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $414,696 and $263,200 for the nine months ended September 30, 2023 and 2022, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

On August 24, 2023, Cavalry converted $60,000 of interest into 173,914 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $28,696. 

 

The balance of the Cavalry Note plus accrued interest at September 30, 2023 was $1,156,093.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

On May 19, 2023, August 16, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

The balance of the Mercer Note plus accrued interest at September 30, 2023 was $1,114,419.

 

Quick Capital, LLC

 

On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 182,194 shares of Common Stock at an initial exercise price of $0.345 per share.

 

The balance of the Quick Capital Note plus accrued interest at September 30, 2023 was $36,870, net of unamortized debt discount of $27,393.

 

1800 Diagonal Street Lending LLC

 

On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

 

On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion. 

 

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, for $194,386, including the principal amount of $180,020, early settlement penalty of $9,306 and interest thereon of $5,060.

 

Red Road Holdings Corporation

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note, bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 17.13%, and maturing on June 15, 2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note plus accrued interest at September 30, 2023 was $10,787, net of unamortized debt discount of $137,354.

 

2023 Convertible Notes

 

Between February 13, 2023 and September 14, 2023, the Company entered into Securities Purchase Agreements with 24 accredited investors, pursuant to which the Company received an aggregate of $1,676,666 in gross proceeds in a private placement through the issuance of:

 

Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

 

five-year warrants (the “2023 Warrants”) to purchase an aggregate 4,682,093 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

The balance of the 2023 Notes plus accrued interest at September 30, 2023 was $1,137,769, net of unamortized debt discount of $580,167.

v3.23.3
Derivative Liability
9 Months Ended
Sep. 30, 2023
Derivative Liability [Abstract]  
DERIVATIVE LIABILITY
14 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 12 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model. These convertible notes were subsequently settled on August 3, 2023, resulting in the elimination of the derivative liability related to these notes.

 

On September 12, 2023, the Company entered into a convertible note agreement with RRH which has variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $243,923 but limited to the cash value of the convertible notes of $125,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the three months ended September 30, 2023 was a net mark-to-market credit of $1,795,642 and for the nine months ended September 30, 2023 was a net market credit of $1,483,710, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

    Nine months
ended
September 30,
2023
    Year ended
December 31,
2022
 
Conversion price   $ 0.114 to $0.345     $ 0.345 to $4.50  
Risk free interest rate     3.60 to 5.55 %     0.79 to 4.73 %
Expected life of derivative liability     3.5 to 47 months       1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 217.01 %     120.49 to 258.3 %
Expected dividend rate     0 %     0 %

 

The movement in derivative liability is as follows:

 

   September 30,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   275,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,483,710)   (411,752)
   $1,341,932   $2,550,642 
v3.23.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY
15 STOCKHOLDERS’ EQUITY

 

a.Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 13,030,034 and 12,563,426 shares of Common Stock issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 13 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 13 above.

 

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    
-
    
-
    66,667    1.65 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding September 30, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at September 30, 2023 is as follows:

 

   Restricted Stock
Granted and
Vested
 
Grant date Price  Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47   683,167   $1.47 
$1.50   33,333    1.50 
$1.65   66,667    1.65 
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 and $172,766 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $298,298 for the nine months ended September 30, 2023 and 2022, respectively. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2023 and December 31, 2022.

 

d.Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 100,000 shares of Common Stock at an exercise price of $4.50 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $0.345 per share. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:

 

The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;

 

The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

Between February 13, 2023 and September 14, 2023, the Company entered into Securities Purchase Agreements with 124 accredited investors, as disclosed in note 13 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 4,682,093 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, Open Path and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of open Path and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of Open Path and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of open Path and EfinityPay an additional IPEX warrant to purchase 166,667 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, Open Path and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months
ended
September 30,
2023
 
Exercise price  $0.345 
Risk free interest rate   3.77 to 4.42 %
Expected life   5 years 
Expected volatility of underlying stock   187.40 to 190.77 %
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,475   $1.50 – 5.625   $3.60 
Granted   1,700,000    0.345 – 1.035    0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,374   $ 0.345 – 5.625   $0.9000 
Granted   4,982,096    0.345 – 4.50    0.3605 
Forfeited   (33,333)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   9,135,137   $0.345 – 5.625   $0.6667 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding and exercisable at September 30, 2023 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    7,748,686    4.29         7,748,686         4.29 
$0.450    266,668    4.73         266,668         
4,73
 
$1.035    500,000    1.77         406,250         1.77 
$1.500    33,334    4.87         33,334         4.87 
$4.50    505,560    2.46         505,560         2.46 
$5.625    80,889    2.46         80,889         2.46 
      9,135,137    3.97   $0.6667    9,041,387   $0.6629    4.07 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 and $0 as of September 30, 2023 and 2022, respectively.

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667  shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 500,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $4.50 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 6,667 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 26,668 shares of Common Stock at an exercise price of $1.20 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

A summary of option activity during the period January 1, 2022 to September 30, 2023 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,225    $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,893    $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   1,543,893    
$1.20 to 12.00
   $4.47 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at September 30, 2023 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    26,668    8.96         26,668         8.96 
$4.50    1,506,946    8.22         1,354,169         8.48 
$7.20    6,945    7.40         6,945         7.40 
$12.00    3,334    5.25         3,334         5.25 
      1,543,893    8.19   $4.47    1,391,116   $4.47    8.23 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2023 and 2022.

 

The option expense was $94,464 and $950,290 for the three months ended September 30, 2023 and 2022, respectively, and $283,392 and $1,139,220 for the nine months ended September 30, 2023 and 2022, respectively.

v3.23.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2023
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE
16 NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of shares of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three months and nine months ended September 30, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2023 and 2022 are as follows:

 

   Three and
nine months
ended
September 30,
2023
(Shares)
   Three and
nine months
ended
September 30,
2022
(Shares)
 
Convertible debt   13,046,469    491,290 
Stock options   1,543,893    1,543,893 
Warrants to purchase shares of Common Stock   9,135,137    1,943,472 
    23,725,499    3,978,655 
v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
17 RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 500,000 shares of Common Stock at an exercise price of $4.50 per share.

 

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms.

 

The option expense for Mr. Corbett was $66,587 and $890,441 for the three months ended September 30, 2023 and 2022, respectively and $199,760 and $1,023,614 for the nine months ended September 30, 2023 and 2022, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

Madisson Butler

 

On September 13, 2022, the Company granted Ms. Butler (formerly known as Madisson Corbett), immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Butler was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022, respectively.

 

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the three months ended September 30, 2023 and 2022, respectively, and $0 and $7,993 for the nine months ended September 30, 2023 and 2022.

 

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 66,667 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $27,879 for each of the three months ended September 30, 2023 and 2022, and $83,636 for each of the nine months ended September 30, 2023 and 2022.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
18 COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which mature between December 30, 2023 and September 14, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
19 SUBSEQUENT EVENTS

 

On October 19, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note, bearing interest at 13%, or $9,548, which interest is earned on issuance of the note and maturing on July 30,2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

On October 20, 2023, the Company entered into Securities Purchase Agreements with an accredited investor, pursuant to which the Company received an aggregate of $50,000 in gross proceeds in a private placement through the issuance of a Convertible Promissory Note and a five-year warrant to purchase an aggregate 144,928 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events. The convertible Promissory Note matures on October 20, 2024 and bears interest at 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

On November 1, 2023, the Company received an extension of the payment date of the third Tranche due under the IPSIPay Express Operating Agreement from October 31, 2023 to November 30, 2023.

 

On November 8, 2023, the Company received a notice of conversion from Cavalry, converting $100,000 of accrued interest into 289,855 shares of common stock at a conversion price of $0.345 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies and Estimates [Abstract]  
Basis of Presentation
a)Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three and nine months ended September 30, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation
b)Principles of Consolidation

The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

Use of Estimates
c)Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Contingencies
d)Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

Fair Value of Financial Instruments
e)Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

Risks and Uncertainties
f)Risks and Uncertainties

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) launching and scaling the IPSIPay Express products and the use by customers of such products, (ii) developing and implementing successful marketing campaigns and other strategic initiatives; (iii) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see notes 11 and 12); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

Recent accounting pronouncements
g)Recent accounting pronouncements

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

Reporting by Segment
h)Reporting by Segment

No segmental information is required as the Company only has one operating segment.

Cash and Cash Equivalents
i)Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

Accounts Receivable and Allowance for Doubtful Accounts
j)Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2023 and December 31, 2022.

Investments
k)Investments

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

Plant and Equipment
l)Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

Long-Term Assets
m)Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition
n)Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

  i. identify the contract with a customer;
  ii. identify the performance obligations in the contract;
  iii. determine the transaction price;
  iv. allocate the transaction price to performance obligations in the contract; and
  v. recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $(28) and $0 for the three months ended September 30, 2023 and 2022, respectively and $410 and $0 for the nine months ended September 30, 2023 and 2022, respectively. 

Share-Based Payment Arrangements
o)Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

Derivative Liabilities
p)Derivative Liabilities

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes
q)Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

Comprehensive income
r)Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

v3.23.3
Accounting Policies and Estimates (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies and Estimates [Abstract]  
Schedule of Estimated Useful Lives of the Assets Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:
Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years
v3.23.3
Disposal of Investment in Frictionless and Beyond Fintech (Tables)
9 Months Ended
Sep. 30, 2023
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
Schedule of Assets and Liabilities The assets and liabilities disposed of as of May 12, 2023 were as follows:
   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
v3.23.3
Novation of Certain Assets and Liabilites (Tables)
9 Months Ended
Sep. 30, 2023
Novation of Certain Assets and Liabilites [Abstract]  
Schedule of Assets and liabilities Novated The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:
   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 
v3.23.3
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2023
Discontinued Operations [Abstract]  
Schedule of Assets and Liabilities The following assets and liabilities are reported as discontinued operations:
   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 

 

Schedule of Statement of Operations from Discontinued Operations The statement of operations from discontinued operations is as follows:
   Three months
ended
   Three months
ended
   Six months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Revenue  $
        -
   $
-
   $
-
   $
-
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    15,618    40,821    59,962 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    15,618    40,821    59,962 
                     
Loss from operations before income taxes   
-
    (15,618)   (40,821)   (59,962)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $(15,618)  $(40,821)  $(59,962)
v3.23.3
Intangibles (Tables)
9 Months Ended
Sep. 30, 2023
Intangibles [Abstract]  
Schedule of Facilitate the Functioning of the IPSIPay Software On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).
    September 30,
2023
    December 31,
2022
 
    Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchased Technology - IPSIPay   $
-
    $
-
    $
-
    $ 1,401,491  
                                 
v3.23.3
Equity Method Investment (Tables)
9 Months Ended
Sep. 30, 2023
Equity Method Investment [Abstract]  
Schedule of Equity Method Investments The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, The movement in equity method investments related to IPSIPay Express for the period ended September 30, 2023 is as follow:
   September 30,
2023
 
Cash contribution to IPSIPay Express  $1,000,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,108,220 
Equity loss from joint venture   (403,890)
   $704,330 
v3.23.3
Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Total Lease Cost Individual components of the total lease cost incurred by the Company is as follows:
   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Operating lease expense  $40,704   $43,200 
Schedule of Other Lease Information Other lease information:
   Nine months
ended
September 30,
2023
   Nine months
ended
September 30,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(43,200)
           
Remaining lease term – operating lease   Monthly    Monthly 
v3.23.3
Notes Payable (Tables)
9 Months Ended
Sep. 30, 2023
Notes Payable [Abstract]  
Schedule of Notes Payable Notes payable to Cavalry and Mercer at September 30, 2023 consists of the following:
Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   September 30,
2023
Amount, net
  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  December 30, 2023   482,000    36,685    518,685    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  December 30, 2023   482,000    36,686    518,686    482,134 
Total convertible notes payable          $964,000   $73,371   $1,037,371   $964,268 
v3.23.3
Convertible Notes Payable (Tables)
9 Months Ended
Sep. 30, 2023
Convertible Notes Payable [Abstract]  
Schedule of Convertible Notes Payable Convertible notes payable consists of the following:
Description  Interest
Rate
    Maturity
date
   Principal   Accrued
Interest
   Unamortized
debt discount
   September 30,
2023
Amount, net
   December 31,
2022
Amount, net
 
Cavalry Fund I LP   10.00%    December 30, 2023    1,091,754    64,339    
-
    1,156,093    1,133,301 
                                     
Mercer Street Global 
Opportunity Fund, LLC
   10.00%    December 30, 2023    991,754    122,665    
-
    1,114,419    1,133,301 
                                     
Quick Capital, LLC   8.00%    December 20, 2023    62,857    1,405    (27,393)   36,869    
-
 
                                     
Red Road Holdings Corporation   17.13%    June 15, 2024    146,900    1,241    (137,354)   10,787    
-
 
                                     
2023 convertible notes   8.00 to 12.00%    December 31, 2023
to September 14, 2024
    1,676,666    41,270    (580,167)   1,137,769    
-
 
                                     
Total convertible notes payable             $3,969,931   $230,920   $(744,914)  $3,455,937   $2,266,602 
v3.23.3
Derivative Liability (Tables)
9 Months Ended
Sep. 30, 2023
Derivative Liability [Abstract]  
Schedule of Assumptions Were Used in the Black-Scholes Valuation Model The following assumptions were used in the Black-Scholes valuation model:
    Nine months
ended
September 30,
2023
    Year ended
December 31,
2022
 
Conversion price   $ 0.114 to $0.345     $ 0.345 to $4.50  
Risk free interest rate     3.60 to 5.55 %     0.79 to 4.73 %
Expected life of derivative liability     3.5 to 47 months       1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 217.01 %     120.49 to 258.3 %
Expected dividend rate     0 %     0 %
Schedule of Movement in Derivative Liability The movement in derivative liability is as follows:
   September 30,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   275,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,483,710)   (411,752)
   $1,341,932   $2,550,642 
v3.23.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Activity A summary of restricted stock activity during the period January 1, 2022 to September 30, 2023 is as follows:
   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    
-
    
-
    66,667    1.65 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding September 30, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Restricted Stock Granted Issued and Exercisable The restricted stock granted, issued and exercisable at September 30, 2023 is as follows:
   Restricted Stock
Granted and
Vested
 
Grant date Price  Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47   683,167   $1.47 
$1.50   33,333    1.50 
$1.65   66,667    1.65 
    783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:
   Nine months
ended
September 30,
2023
 
Exercise price  $0.345 
Risk free interest rate   3.77 to 4.42 %
Expected life   5 years 
Expected volatility of underlying stock   187.40 to 190.77 %
Expected dividend rate   0%
Schedule of Warrant Activity A summary of warrant activity during the period January 1, 2022 to September 30, 2023 is as follows:
   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,475   $1.50 – 5.625   $3.60 
Granted   1,700,000    0.345 – 1.035    0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,374   $ 0.345 – 5.625   $0.9000 
Granted   4,982,096    0.345 – 4.50    0.3605 
Forfeited   (33,333)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   9,135,137   $0.345 – 5.625   $0.6667 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

Schedule of Warrants Outstanding and Exercisable The warrants outstanding and exercisable at September 30, 2023 are as follows:
    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    7,748,686    4.29         7,748,686         4.29 
$0.450    266,668    4.73         266,668         
4,73
 
$1.035    500,000    1.77         406,250         1.77 
$1.500    33,334    4.87         33,334         4.87 
$4.50    505,560    2.46         505,560         2.46 
$5.625    80,889    2.46         80,889         2.46 
      9,135,137    3.97   $0.6667    9,041,387   $0.6629    4.07 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Option Activity A summary of option activity during the period January 1, 2022 to September 30, 2023 is as follows:
   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,225    $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,893    $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2023   1,543,893    
$1.20 to 12.00
   $4.47 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Options Outstanding and Exercisable The options outstanding and exercisable at September 30, 2023 are as follows:
    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    26,668    8.96         26,668         8.96 
$4.50    1,506,946    8.22         1,354,169         8.48 
$7.20    6,945    7.40         6,945         7.40 
$12.00    3,334    5.25         3,334         5.25 
      1,543,893    8.19   $4.47    1,391,116   $4.47    8.23 
v3.23.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Loss Per Share [Abstract]  
Schedule of Dilutive Shares Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2023 and 2022 are as follows:
   Three and
nine months
ended
September 30,
2023
(Shares)
   Three and
nine months
ended
September 30,
2022
(Shares)
 
Convertible debt   13,046,469    491,290 
Stock options   1,543,893    1,543,893 
Warrants to purchase shares of Common Stock   9,135,137    1,943,472 
    23,725,499    3,978,655 
v3.23.3
Organization and Description of Business (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 12, 2023
Feb. 03, 2022
Jun. 22, 2021
Dec. 31, 2019
Aug. 30, 2022
Aug. 26, 2021
Sep. 30, 2022
Sep. 30, 2023
Oct. 31, 2023
Sep. 15, 2023
Aug. 04, 2023
Jun. 21, 2023
Feb. 16, 2021
Nov. 01, 2019
Organization and Description of Business [Abstract]                            
Shares of common stock 30,000,000 3,000,000           621,920            
Aggregate shares of common stock               2,500         51,901,711  
Retained shares of common stock               500,000            
Outstanding shares of common stock                           32,047,817
Stock purchase agreement       2,250,000                    
Shares of vivi       9.00%                    
capital contribution (in Dollars)               $ 1,500,000            
Percentage of membership interest               11.11%            
Initial tranche (in Dollars)                       $ 200,000    
Exercise price per share (in Dollars per share)               $ 0.45            
Warrants to purchase of common stock 30,000,000             39,130,435         2,486,957  
Percentage of remaining shares owned           49.00%                
Beyond fintech shares (in Dollars)               $ 250,000            
Proceeds from impairment (in Dollars) $ 231,431                          
Beyond Fintech [Member]                            
Organization and Description of Business [Abstract]                            
Ownership percentage           51.00%                
Common Stock [Member]                            
Organization and Description of Business [Abstract]                            
Common stock, par value (in Dollars per share)               $ 0.0001            
Common stock shares holder current               500,000            
Aggregate shares of common stock         100,000                  
Common stock outstanding, percentage               91.00%            
Outstanding shares of common stock                           320,477,867
Exchange shares [1]             233,333              
Exercise price per share (in Dollars per share)         $ 4.5                  
Maximum [Member]                            
Organization and Description of Business [Abstract]                            
capital contribution (in Dollars)               $ 500,000            
Share-Based Payment Arrangement, Tranche One [Member]                            
Organization and Description of Business [Abstract]                            
Initial tranche (in Dollars)                     $ 300,000      
Share-Based Payment Arrangement, Tranche Two [Member]                            
Organization and Description of Business [Abstract]                            
Initial tranche (in Dollars)                   $ 500,000        
Share-Based Payment Arrangement, Tranche Three [Member]                            
Organization and Description of Business [Abstract]                            
Initial tranche (in Dollars)                 $ 500,000          
Capital Contribution [Member] | Maximum [Member]                            
Organization and Description of Business [Abstract]                            
Warrants to purchase of common stock               1,333,334,000,000            
Capital Contribution [Member] | Minimum [Member]                            
Organization and Description of Business [Abstract]                            
Warrants to purchase of common stock               166,667,000,000            
Warrant [Member]                            
Organization and Description of Business [Abstract]                            
Warrants to purchase of common stock               199,999,000,000            
Warrant [Member]                            
Organization and Description of Business [Abstract]                            
Aggregate shares of common stock               133,334            
Business Combination [Member]                            
Organization and Description of Business [Abstract]                            
Acquired interest               1.00%            
Vivi Holdings, Inc [Member]                            
Organization and Description of Business [Abstract]                            
Exchange shares       2,250,000                    
Frictionless [Member]                            
Organization and Description of Business [Abstract]                            
Variable interest entity ownership percentage     10.00%                      
Common stock outstanding percentage               41.00%            
Purchase price (in Dollars)               $ 300,000            
Qpagos Corporation’s Capital Stock [Member]                            
Organization and Description of Business [Abstract]                            
Shares of common stock               4,992,900            
Qpagos Corporation’s Capital Stock [Member] | Common Stock [Member]                            
Organization and Description of Business [Abstract]                            
Shares of common stock               497,500            
Gaston Pereira [Member]                            
Organization and Description of Business [Abstract]                            
Shares of vivi       5.00%                    
Andrey Novikov [Member]                            
Organization and Description of Business [Abstract]                            
Shares of vivi       2.50%                    
Joseph Abrams [Member]                            
Organization and Description of Business [Abstract]                            
Shares of vivi       1.50%                    
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Accounting Policies and Estimates (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Aug. 26, 2021
Accounting Policies and Estimates [Abstract]            
Operating segment     1      
Federally insured limit $ 0   $ 0   $ 120,580  
Ownership stake percentage     20.00%      
Plant and equipment costs 1,000   $ 1,000      
Revenues $ (28) $ 410    
Beyond Fintech Inc. [Member]            
Accounting Policies and Estimates [Abstract]            
Ownership percentage 51.00%   51.00%     51.00%
v3.23.3
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets
Sep. 30, 2023
Kiosks [Member]  
Estimated Useful Life 7 years
Computer equipment [Member]  
Estimated Useful Life 3 years
Office equipment [Member]  
Estimated Useful Life 10 years
v3.23.3
Liquidity Matters and Going Concern (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Schedule of liquidity matters and going concern [Abstract]                  
Net loss $ (1,015,143) [1] $ (3,174,217) [1] $ (274,987) [1] $ (3,310,496) [1] $ (1,087,332) [1] $ (1,810,246) [1] $ (4,464,347) $ (6,208,074) $ (10,331,424)
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Disposal of Investment in Frictionless and Beyond Fintech (Details) - USD ($)
May 12, 2023
Sep. 30, 2023
Feb. 16, 2021
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Warrants to purchase of common stock (in Shares) 30,000,000 39,130,435 2,486,957
Consideration received on per transations (in Dollars) $ 250,000    
Credit rate 20.00%    
Ownership [Member]      
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Minority interest ownership percentage 10.00%    
Beyond Fintech [Member]      
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Ownership interest rate 51.00%    
v3.23.3
Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities - Frictionless And Beyond Fintech [Member]
4 Months Ended
May 12, 2023
USD ($)
Current Assets  
Cash $ 339
Non-current assets  
Intangible assets 327,211
Security deposit 15,000
Investment 500,000
Total Non-current assets 842,211
Total assets 842,550
Current Liabilities  
Accounts payable 97,126
Net assets sold 745,424
Proceeds due on disposal (250,000)
Net loss on disposal $ 495,424
v3.23.3
Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated - Novation Certin [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
Current Assets  
Receivable on sale of subsidiary $ 231,431
Non-current assets  
Intangible assets 1,098,598
Total assets 1,330,029
Current Liabilities  
Accounts payable 263,864
Net loss on novation $ 1,066,165
v3.23.3
Discontinued Operations (Details) - Schedule of Assets and Liabilities
Dec. 31, 2022
USD ($)
Current assets  
Cash $ 943
Non-current assets  
Intangibles, net 291,320
Investment 500,000
Security deposit 15,000
Assets held for sale 807,263
Current liabilities  
Accounts payable 33,810
Liabilities held for sale $ 33,810
v3.23.3
Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations - Discontinued Operations [Member] - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Condensed Statement of Income Captions [Line Items]        
Net Revenue
Cost of Goods Sold
Gross loss
General and administrative 15,618 40,821 59,962
Depreciation and amortization
Total Expense 15,618 40,821 59,962
Loss from operations before income taxes (15,618) (40,821) (59,962)
Income Taxes
Loss from discontinued operations, net of taxation $ (15,618) $ (40,821) $ (59,962)
v3.23.3
Intangibles (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 26, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Intangibles (Details) [Line Items]              
Gross proceeds $ 250,000           $ 375,000
Intangible assets          
IPSIPay software amount       44,405   $ 1,127,400  
Amortization expense   93,095 $ 12,629 347,298 $ 12,629    
Software [Member]              
Intangibles (Details) [Line Items]              
Intangible assets   $ 35,891   $ 35,891   $ 41,320  
Beyond Fintech [Member]              
Intangibles (Details) [Line Items]              
Ownership percentage 51.00% 51.00%   51.00%      
Frictionless [Member]              
Intangibles (Details) [Line Items]              
Ownership percentage 49.00%            
v3.23.3
Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of Facilitate the Functioning of the IPSIPay Software [Abstract]    
Cost  
Accumulated amortization  
Net Book Value $ 1,401,491
v3.23.3
Equity Method Investment (Details)
Sep. 30, 2023
USD ($)
Equity Method Investment [Abstract]  
Capital contribution initial tranche amount $ 500,000
Capital contribution second tranche amount $ 500,000
v3.23.3
Equity Method Investment (Details) - Schedule of Equity Method Investments - IPSIPay Express [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]  
Cash contribution to IPSIPay Express $ 1,000,000
Fair value of warrants issued to third party joint venture partners 108,220
Equity total 1,108,220
Equity loss from joint venture (403,890)
Joint venture total $ 704,330
v3.23.3
Investments (Details)
May 12, 2023
Ownership [Member]  
Investments (Details) [Line Items]  
Ownership interest 10.00%
v3.23.3
Leases (Details) - USD ($)
9 Months Ended
Jan. 01, 2023
Sep. 30, 2023
Leases [Abstract]    
Lease, description   The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022.
Lease amount   $ 4,800
Rent payments $ 5,088  
v3.23.3
Leases (Details) - Schedule of Total Lease Cost - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Schedule of Total Lease Cost [Abstract]    
Operating lease expense $ 40,704 $ 43,200
v3.23.3
Leases (Details) - Schedule of Other Lease Information - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (40,704) $ (43,200)
Remaining lease term – operating lease Monthly Monthly
v3.23.3
Federal Relief Loans (Details) - Small Business Economic Injury Disaster Loan [Member] - USD ($)
9 Months Ended
Jul. 07, 2020
Sep. 30, 2023
Federal Relief Loans (Details) [Line Items]    
Loan amount $ 150,000 $ 147,136
Interest rate 3.75%  
Loan monthly payment $ 731  
Principal amount   2,864
Aggregate principal amount interest   3,715
Accrued interest   14,432
Accrued interest disclosed as current   $ 3,295
v3.23.3
Notes Payable (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 16, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
May 12, 2023
Dec. 30, 2022
Sep. 13, 2022
Notes Payable (Details) [Line Items]                
Debt principal amount   $ 964,000   $ 964,000        
Warrants issued to purchase of common stock (in Shares) 2,486,957 39,130,435   39,130,435   30,000,000    
Exercise price (in Dollars per share) $ 0.24             $ 1.2
Non-convertible promissory notes $ 482,000              
Notes issued       $ 964,000        
Interest expense   $ 24,635 $ 0 $ 73,371 $ 0      
Warrant [Member]                
Notes Payable (Details) [Line Items]                
Warrants issued to purchase of common stock (in Shares)   199,999,000,000   199,999,000,000        
Warrants       $ 43,608        
Amendment Transaction [Member]                
Notes Payable (Details) [Line Items]                
Interest rate       10.00%        
Non-convertible promissory notes             $ 482,000  
Maturity date       Dec. 30, 2023        
Conversion shares issued (in Shares)       51,901,711        
Cavalry and Mercer [Member]                
Notes Payable (Details) [Line Items]                
Interest rate 12.50%              
Convertible Debt [Member]                
Notes Payable (Details) [Line Items]                
Convertible debt   $ 920,392   $ 920,392        
Cavalry Fund I LP [Member]                
Notes Payable (Details) [Line Items]                
Company received $ 500,500              
Debt principal amount   482,000   482,000        
Mercer Street Global Opportunity Fund, LLC [Member]                
Notes Payable (Details) [Line Items]                
Company received 500,500              
Debt principal amount   $ 482,000   $ 482,000        
Cavalry and Mercer [Member]                
Notes Payable (Details) [Line Items]                
Debt principal amount $ 572,000              
v3.23.3
Notes Payable (Details) - Schedule of Notes Payable - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Notes Payable (Details) - Schedule of Notes Payable [Line Items]    
Principal $ 964,000  
Accrued Interest 73,371  
Amount, net $ 1,037,371 $ 964,268
Cavalry Fund I LP [Member]    
Notes Payable (Details) - Schedule of Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date Dec. 30, 2023  
Principal $ 482,000  
Accrued Interest 36,685  
Amount, net $ 518,685 482,134
Mercer Street Global Opportunity Fund, LLC [Member]    
Notes Payable (Details) - Schedule of Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date Dec. 30, 2023  
Principal $ 482,000  
Accrued Interest 36,686  
Amount, net $ 518,686 $ 482,134
v3.23.3
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 09, 2023
Aug. 03, 2023
Jun. 13, 2023
May 12, 2023
May 10, 2023
Feb. 03, 2022
Feb. 16, 2021
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
Jun. 20, 2023
May 19, 2023
Dec. 28, 2022
Nov. 16, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 30, 2022
Sep. 14, 2023
Jun. 15, 2023
Convertible Notes Payable [Line Items]                                            
Maturity date           Aug. 16, 2022 Dec. 30, 2023                              
Interest rate percentage             10.00%                              
Additional shares of common stock (in Shares)       30,000,000   3,000,000                     621,920          
Exercise price per share (in Dollars per share)                         $ 0.0115       $ 0.345          
Shares of common stock (in Shares)                             3,000,000   3,000,000          
Warrant exercisable (in Shares)       30,000,000     2,486,957               39,130,435   39,130,435          
Non-convertible promissory notes             $ 482,000                              
Common stock shares issued (in Shares)             51,901,711               2,500   2,500          
Common stock price per share (in Dollars per share)                                       $ 0.06    
Aggregate amount                         $ 2,264,784                  
Convertible notes                                 $ 836,414          
Black-scholes valuation model                                 1,499,577          
Convertible note holders                             $ 238,182   238,182          
Additional charge                             $ 14,176 [1] $ 322,918 [1] $ 920,392          
Warrant share (in Shares)                                        
Value of notes                             $ 964,000   $ 964,000          
Holders amount                                 841,003          
Interest expense                             83,829 49,912 212,886 $ 138,085        
Amortization of debt discount total                             303,042 414,696 263,200        
Converted interest                                 160,000        
Loss on conversion                 $ 28,696                          
Accrued interest                             73,371   73,371          
Net of unamortized debt discount                             744,914   744,914   $ 0      
Issuance of convertible note     $ 62,700                                      
Bearing interest rate     17.33%                                      
Principal amount                             964,000   964,000          
Settlement penalty                             (9,306) $ (602,100) $ (9,306) $ (1,321,658)        
Aggregate of gross proceeds received                                         $ 1,676,666  
Purchase of aggregate shares (in Shares)                                 4,682,093          
Beneficially own of percentage                                 4.99%          
Limitation exceeds of percentage                                 9.99%          
Cavalry Fund LLP [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage             10.00%             20.00%                
Exercise price per share (in Dollars per share)             $ 7.2             $ 4.5                
Warrant exercisable (in Shares)             82,899                              
Net proceeds             $ 500,500                              
Original issue discount             71,500                              
Senior secured convertible note             $ 572,000                              
Initial conversion price per share (in Dollars per share)             $ 0.23                              
Purchase an additional shares (in Shares)                           100,000                
Converted interest                 $ 60,000                          
Cavalry Fund I LP [Member]                                            
Convertible Notes Payable [Line Items]                                            
Common stock conversion price (in Shares)                 173,914                          
Conversion price per share (in Dollars per share)                 $ 0.345                          
Accrued interest                             1,156,093   $ 1,156,093          
Mercer Street Global Opportunity Fund, LLC [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage                           20.00%                
Exercise price per share (in Dollars per share)             $ 7.2             $ 4.5                
Warrant exercisable (in Shares)             82,899                              
Net proceeds             $ 500,500                              
Original issue discount             572,000                              
Senior secured convertible note             $ 71,500                              
Purchase an additional shares (in Shares)                           100,000                
Accrued interest                             1,114,419   1,114,419          
Original issue discount rate             10.00%                              
Conversion price (in Dollars per share)             $ 6.9                              
Mercer converted [Member]                                            
Convertible Notes Payable [Line Items]                                            
Converted interest               $ 100,000   $ 100,000   $ 100,000                    
Common stock conversion price (in Shares)                       289,856                    
Conversion price per share (in Dollars per share)                       $ 0.345                    
Loss on conversion                       $ 48,551                    
Quick Capital, LLC [Member]                                            
Convertible Notes Payable [Line Items]                                            
Exercise price per share (in Dollars per share)                     $ 0.345                      
Warrant exercisable (in Shares)                     182,194                      
Net proceeds                     $ 50,000                      
Original issue discount                     62,857                      
Senior secured convertible note                     $ 12,857                      
Accrued interest                             36,870   36,870          
Original issue discount rate                     8.00%                      
Conversion price (in Dollars per share)                     $ 0.345                      
Net of unamortized debt discount                             27,393   27,393          
Diagonal Street Lending LLC [Member]                                            
Convertible Notes Payable [Line Items]                                            
Net proceeds         $ 100,000                                  
Original issue discount         117,320                                  
Senior secured convertible note         $ 17,320                                  
Accrued interest                             10,787   10,787          
Original issue discount rate         13.00%                                  
Net of unamortized debt discount                             $ 137,354   $ 137,354          
Variable conversion rate percentage     60.00%   60.00%                                  
Principal amount   $ 194,386                                        
Gross proceeds   180,020                                        
Settlement penalty   9,306                                        
Interest thereon   $ 5,060                                        
Red Road Holdings Corporation [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage 13.00%                                          
Original issue discount $ 146,900                                          
Variable conversion rate percentage                                           60.00%
Effective interest rate 17.13%                                          
Minimum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage                             8.00%   8.00%          
Maximum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage                             12.00%   12.00%          
Cavalry and Mercer [Member] | Minimum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                             $ 0.15   $ 0.15          
Cavalry and Mercer [Member] | Maximum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                             0.0115   0.0115          
Debt instrument [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                             0.345   0.345          
Debt instrument [Member] | Minimum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                             0.0115   0.0115          
Debt instrument [Member] | Maximum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                             $ 0.15   0.15          
Cavalry Fund LLP [Member] | Minimum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price per share (in Dollars per share)                           $ 4.5                
Cavalry Fund LLP [Member] | Maximum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price per share (in Dollars per share)                           $ 0.345                
Mercer Street Global Opportunity Fund, LLC [Member] | Minimum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                                       4.5    
Mercer Street Global Opportunity Fund, LLC [Member] | Maximum [Member]                                            
Convertible Notes Payable [Line Items]                                            
Conversion price, per share (in Dollars per share)                                       0.345    
Warrant [Member]                                            
Convertible Notes Payable [Line Items]                                            
Exercise price per share (in Dollars per share)                                        
Warrant exercisable (in Shares)                             199,999,000,000   199,999,000,000          
Accrued interest                             $ 1,137,769   $ 1,137,769          
Net of unamortized debt discount                             $ 580,167   $ 580,167          
Convertible Debt [Member] | Diagonal Street Lending LLC [Member]                                            
Convertible Notes Payable [Line Items]                                            
Accrued interest $ 125,000                                          
Net of unamortized debt discount $ 21,900                                          
Cavalry and Mercer [Member]                                            
Convertible Notes Payable [Line Items]                                            
Interest rate percentage           20.00%                                
Exercise price per share (in Dollars per share)           $ 0.15                           $ 0.04    
Aggregate amount                         $ 1,132,392                  
Net proceeds     $ 50,000                                      
Original issue discount     $ 12,700                                      
Principal amount             $ 572,000                              
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Convertible Notes Payable [Line Items]    
Principal $ 3,969,931  
Accrued Interest 230,920  
Unamortized debt discount (744,914) $ 0
Total convertible notes payable $ 3,455,937 2,266,602
Cavalry Fund I LP [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date December 30, 2023  
Principal $ 1,091,754  
Accrued Interest 64,339  
Unamortized debt discount  
Total convertible notes payable $ 1,156,093 1,133,301
Mercer Street Global Opportunity Fund, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date December 30, 2023  
Principal $ 991,754  
Accrued Interest 122,665  
Unamortized debt discount  
Total convertible notes payable $ 1,114,419 1,133,301
Quick Capital, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 8.00%  
Maturity date December 20, 2023  
Principal $ 62,857  
Accrued Interest 1,405  
Unamortized debt discount (27,393)  
Total convertible notes payable $ 36,869
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 17.13%  
Maturity date June 15, 2024  
Principal $ 146,900  
Accrued Interest 1,241  
Unamortized debt discount (137,354)  
Total convertible notes payable $ 10,787
2023 convertible notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Maturity date December 31, 2023 to September 14, 2024  
Principal $ 1,676,666  
Accrued Interest 41,270  
Unamortized debt discount (580,167)  
Total convertible notes payable $ 1,137,769
2023 convertible notes [Member] | Minimum [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 8.00%  
2023 convertible notes [Member] | Maximum [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 12.00%  
v3.23.3
Derivative Liability (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Sep. 12, 2023
Jun. 13, 2023
May 10, 2023
Derivative Liability (Details) [Line Items]          
Rachet provision   $ 474,614      
Convertible notes     $ 243,923 $ 150,000 $ 360,491
Derivative liability movements $ 1,795,642 1,483,710      
Warrant [Member]          
Derivative Liability (Details) [Line Items]          
Derivative liability $ 2,317,051 $ 2,317,051      
Black-Scholes [Member]          
Derivative Liability (Details) [Line Items]          
Convertible notes     $ 125,000    
v3.23.3
Derivative Liability (Details) - Schedule of Assumptions Were Used in the Black-Scholes Valuation Model - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Conversion price (in Dollars per share) $ 0.114 $ 0.345
Risk free interest rate 3.60% 0.79%
Expected life of derivative liability 3 months 15 days 1 month 15 days
Expected volatility of underlying stock 158.72% 120.49%
Maximum [Member]    
Conversion price (in Dollars per share) $ 0.345 $ 4.5
Risk free interest rate 5.55% 4.73%
Expected life of derivative liability 47 months 59 months
Expected volatility of underlying stock 217.01% 258.30%
v3.23.3
Derivative Liability (Details) - Schedule of Movement in Derivative Liability - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Opening balance $ 2,550,642 $ 407,161
Derivative financial liability arising from convertible note and warrants 275,000 238,182
Derivative financial liability arising on note amendment included in loss on convertible notes 2,317,051
Fair value adjustment to derivative liability (1,483,710) (411,752)
Total $ 1,341,932 $ 2,550,642
v3.23.3
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 19, 2023
Dec. 30, 2022
Sep. 13, 2022
Jul. 11, 2022
Oct. 22, 2021
Dec. 31, 2019
Aug. 31, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
Aug. 30, 2022
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Feb. 16, 2021
Stockholders’ Equity (Details) [Line Items]                                    
Common stock authorized                       750,000,000     750,000,000   750,000,000  
Common stock par value (in Dollars per share)                       $ 0.0001     $ 0.0001   $ 0.0001  
Common stock issued                       13,030,034     13,030,034   12,563,426  
Common stock conversion shares 72,464           144,928 2,838 173,914 72,464                
Convertible debt (in Dollars) $ 25,000           $ 50,000     $ 25,000                
Interest on convertible debt (in Dollars)                 $ 60,000                  
Expense (in Dollars)                       $ 0   $ 172,766 $ 0 $ 298,298    
Preferred stock, authorized                       25,000,000     25,000,000   25,000,000  
Preferred stock, par value (in Dollars per share)                       $ 0.0001     $ 0.0001   $ 0.0001  
Description of compensation service                             (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date.      
Shares of common stock                       2,500     2,500     51,901,711
Exercise price (in Dollars per share)                             $ 0.45      
Expiration date                     Aug. 30, 2027              
Purchased shares           2,250,000                        
Exercise price (in Dollars per share)     $ 1.2                             $ 0.24
Note amendment transaction description                             the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred: ●The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above; ●The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ●An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.        
Limitation exceeds percentage                             9.99%      
Purchase an aggregate shares                             133,334      
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in Dollars per share)                             $ 0.45      
Purchase shares of common stock                             166,667      
Additional purchase shares of common stock                             166,667      
Aggregate purchase of common stock                             1,333,334      
Warrants outstanding an intrinsic value (in Dollars)                       $ 0   0 $ 0 0    
Incentive stock options       500,000                            
Amount of immediate expense (in Dollars)                                 $ 31,970  
Options exercisable shares     6,667                              
Intrinsic value outstanding options (in Dollars)                       0   0 0 0    
Option expense (in Dollars)                       $ 94,464   $ 950,290 $ 283,392 $ 1,139,220    
Common Stock [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Common stock conversion shares [1]                       391,306 72,464          
Reverse stock split [1]                       2,838            
Shares of common stock                     100,000              
Exercise price (in Dollars per share)                     $ 4.5              
Exercise price (in Dollars per share)   $ 0.345                                
Options exercisable shares     26,668                              
Maximum [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Shares of common stock                       26,667     26,667      
Maximum [Member] | Common Stock [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Shares of common stock                       100,000     100,000      
Minimum [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Reverse stock split             1                      
Minimum [Member] | Common Stock [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Reverse stock split               1                    
Maximum [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Reverse stock split             30                      
Warrants beneficially percentage                             4.99%      
Maximum [Member] | Common Stock [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Reverse stock split               30                    
Warrant [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Purchased shares   1,000,000                                
Fair value of warrants (in Dollars)   $ 348,938                                
Purchase an aggregate shares                             199,999      
Chief Executive Officer [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Stock option exercise price (in Dollars per share)       $ 4.5                            
Amount of immediate expense (in Dollars)                                 $ 823,854  
Debt Conversion Notices [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Aggregate shares of common stock                             4,682,093      
Convertible debt amount (in Dollars)                             $ 0.345      
2021 Stock Incentive Plan [Member] | Maximum [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Shares of common stock         1,766,667                          
2018 Stock Incentive Plan [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Terminates period                             10 years      
2021 Stock Incentive Plan [Member]                                    
Stockholders’ Equity (Details) [Line Items]                                    
Terminates period         10 years                          
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Total restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total restricted shares, Outstanding at beginning [1] 783,167 716,500
Total restricted shares, Granted and issued [1] 66,667
Total restricted shares, Forfeited/Cancelled [1]
Total restricted shares, Vested [1]
Total restricted shares, Outstanding at ending [1] 783,167 783,167
Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.47
Weighted average fair market value per share, Granted and issued [1] 1.65
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1]
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
Total unvested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 170,792 341,583
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] (170,792) (170,791)
Total unvested restricted shares, Outstanding at ending [1] 170,792
Unvested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.47 $ 1.47
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] (1.47) (1.47)
Weighted average fair market value per share, Outstanding at ending [1] $ 1.47
Total vested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total vested restricted shares, Outstanding at beginning [1] 612,375 374,917
Total vested restricted shares, Granted and issued [1] 66,667
Total vested restricted shares, Forfeited/Cancelled [1]
Total vested restricted shares, Vested [1] 170,792 170,791
Total vested restricted shares, Outstanding at ending [1] 783,167 612,375
Vested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.47
Weighted average fair market value per share, Granted and issued [1] 1.65
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] 1.47 1.47
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted Issued and Exercisable
9 Months Ended
Sep. 30, 2023
$ / shares
shares
[1]
Restricted stock granted and Vested, number granted | shares 783,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant date Price 0.049 [Member]  
Restricted stock granted and Vested, number granted | shares 683,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.47
Grant date Price 0.050 [Member]  
Restricted stock granted and Vested, number granted | shares 33,333
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant date Price 0.055 [Member]  
Restricted stock granted and Vested, number granted | shares 66,667
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.65
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model - Warrants [Member]
9 Months Ended
Sep. 30, 2023
$ / shares
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]  
Exercise price (in Dollars per share) $ 0.345
Expected life 5 years
Expected dividend rate 0.00%
Minimum [Member]  
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]  
Risk free interest rate 3.77%
Expected volatility of underlying stock 187.40%
Maximum [Member]  
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Black Scholes Valuation Model [Line Items]  
Risk free interest rate 4.42%
Expected volatility of underlying stock 190.77%
v3.23.3
Stockholders’ Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Product Warranty Liability [Line Items]    
Outstanding January 1, 2022 (in Shares) [1] 5,186,374 1,243,475
Outstanding January 1, 2022 [1] $ 0.9 $ 3.6
Shares Underlying Warrants, Granted (in Shares) [1] 4,982,096 1,700,000
Weighted average exercise price, Granted [1] $ 0.3605 $ 0.5478
Shares Underlying Warrants, Forfeited (in Shares) [1] (33,333)  
Exercise price per share, Forfeited [1] $ 1.5  
Weighted average exercise price, Forfeited [1] $ 1.5  
Shares Underlying Warrants, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares) [1] (1,000,000)  
Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1] $ 0.345  
Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1] $ 0.345  
Shares Underlying Warrants, Increase in warrants due to debt amendment full rachet trigger (in Shares) [1]   2,408,696
Exercise price per share, Increase in warrants due to debt amendment full rachet trigger [1]   $ 0.345
Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger [1]   $ 0.345
Shares Underlying Warrants, Cancelled on debt amendment (in Shares) [1]   (165,797)
Exercise price per share, Cancelled on debt amendment [1]   $ 4.5
Weighted average exercise price, Cancelled on debt amendment [1]   $ 4.5
Shares Underlying Warrants, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Outstanding December 31, 2022 (in Shares) [1] 9,135,137 5,186,374
Outstanding December 31, 2022 [1] $ 0.6667 $ 0.9
Minimum [Member]    
Product Warranty Liability [Line Items]    
Outstanding January 1, 2022 [1] 0.345 1.5
Exercise price per share, Granted [1] 0.345 0.345
Outstanding December 31, 2022 [1] 0.345 0.345
Maximum [Member]    
Product Warranty Liability [Line Items]    
Outstanding January 1, 2022 [1] 5.625 5.625
Exercise price per share, Granted [1] 4.5 1.035
Outstanding December 31, 2022 [1] $ 5.625 $ 5.625
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Sep. 30, 2023
Warrants Outstanding [Member]    
Warrants Outstanding, Number Outstanding (in Shares) [1]   9,135,137
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   3 years 11 months 19 days
Warrants Outstanding, Weighted Average Exercise Price [1]   $ 0.6667
Warrants Outstanding [Member] | Exercise Price 0.0115 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 0.345
Warrants Outstanding, Number Outstanding (in Shares) [1]   7,748,686
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   4 years 3 months 14 days
Warrants Outstanding [Member] | Exercise Price 0.0345 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 0.45
Warrants Outstanding, Number Outstanding (in Shares) [1]   266,668
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   4 years 8 months 23 days
Warrants Outstanding [Member] | Exercise Price 0.015 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 1.035
Warrants Outstanding, Number Outstanding (in Shares) [1]   500,000
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   1 year 9 months 7 days
Warrants Outstanding [Member] | Exercise Price 1.500 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 1.5
Warrants Outstanding, Number Outstanding (in Shares) [1]   33,334
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   4 years 10 months 13 days
Warrants Outstanding [Member] | Exercise Price 0.1875 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 4.5
Warrants Outstanding, Number Outstanding (in Shares) [1]   505,560
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   2 years 5 months 15 days
Warrants Outstanding [Member] | Exercise Price 5.625 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 5.625
Warrants Outstanding, Number Outstanding (in Shares) [1]   80,889
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1]   2 years 5 months 15 days
Warrants Exercisable [Member]    
Warrants Outstanding, Exercise Price [1]   $ 9,041,387
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 4 years 25 days  
Warrants Outstanding, Weighted Average Exercise Price [1] $ 0.6629  
Warrants Exercisable [Member] | Exercise Price 0.0115 [Member]    
Warrants Outstanding, Exercise Price [1]   7,748,686
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 4 years 3 months 14 days  
Warrants Exercisable [Member] | Exercise Price 0.0345 [Member]    
Warrants Outstanding, Exercise Price [1]   266,668
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 473 years  
Warrants Exercisable [Member] | Exercise Price 0.015 [Member]    
Warrants Outstanding, Exercise Price [1]   406,250
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 1 year 9 months 7 days  
Warrants Exercisable [Member] | Exercise Price 1.500 [Member]    
Warrants Outstanding, Exercise Price [1]   33,334
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 4 years 10 months 13 days  
Warrants Exercisable [Member] | Exercise Price 0.1875 [Member]    
Warrants Outstanding, Exercise Price [1]   505,560
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 2 years 5 months 15 days  
Warrants Exercisable [Member] | Exercise Price 5.625 [Member]    
Warrants Outstanding, Exercise Price [1]   $ 80,889
Warrants Outstanding, Weighted Average Remaining Contractual life in years [1] 2 years 5 months 15 days  
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Option Activity - Stock Options [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Outstanding January 1, 2022 (in Shares) [1] 1,543,893 1,017,225
Outstanding January 1, 2022 [1] $ 4.47 $ 4.5
Shares Underlying options, Granted (in Shares) [1] 526,668
Exercise price per share, Granted [1]  
Weighted average exercise price, Granted [1] $ 4.2
Shares Underlying options, Forfeited/Cancelled (in Shares) [1]
Exercise price per share, Forfeited/Cancelled [1]
Weighted average exercise price, Forfeited/Cancelled [1]
Shares Underlying options, Exercised (in Shares) [1]
Exercise price per share, Exercised (in Shares) [1]
Weighted average exercise price, Exercised [1]
Outstanding December 31, 2022 (in Shares) [1] 1,543,893 1,543,893
Outstanding December 31, 2022 [1]  
Outstanding December 31, 2022 [1] 4.47 $ 4.47
Minimum [Member]    
Outstanding January 1, 2022 [1] 1.2 4.5
Exercise price per share, Granted [1]   1.2
Outstanding December 31, 2022 [1] 1.2 1.2
Maximum [Member]    
Outstanding January 1, 2022 [1] 12 12
Exercise price per share, Granted [1]   4.5
Outstanding December 31, 2022 [1] $ 12 $ 12
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.23.3
Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Options Outstanding [Member]  
Number Outstanding 1,543,893
Weighted Average Remaining Contractual life in years 8 years 2 months 8 days
Weighted Average Exercise Price | $ / shares $ 4.47
Options Outstanding [Member] | Exercise Price 0.04 [Member]  
Exercise Price | $ / shares $ 1.2
Number Outstanding 26,668
Weighted Average Remaining Contractual life in years 8 years 11 months 15 days
Options Outstanding [Member] | Exercise Price 0.15 [Member]  
Exercise Price | $ / shares $ 4.5
Number Outstanding 1,506,946
Weighted Average Remaining Contractual life in years 8 years 2 months 19 days
Options Outstanding [Member] | Exercise Price 0.24 [Member]  
Exercise Price | $ / shares $ 7.2
Number Outstanding 6,945
Weighted Average Remaining Contractual life in years 7 years 4 months 24 days
Options Outstanding [Member] | Exercise Price 0.40 [Member]  
Exercise Price | $ / shares $ 12
Number Outstanding 3,334
Weighted Average Remaining Contractual life in years 5 years 3 months
Options Exercisable [Member]  
Weighted Average Remaining Contractual life in years 8 years 2 months 23 days
Weighted Average Exercise Price | $ / shares $ 4.47
Number Exercisable 1,391,116
Options Exercisable [Member] | Exercise Price 0.04 [Member]  
Weighted Average Remaining Contractual life in years 8 years 11 months 15 days
Number Exercisable 26,668
Options Exercisable [Member] | Exercise Price 0.15 [Member]  
Weighted Average Remaining Contractual life in years 8 years 5 months 23 days
Number Exercisable 1,354,169
Options Exercisable [Member] | Exercise Price 0.24 [Member]  
Weighted Average Remaining Contractual life in years 7 years 4 months 24 days
Number Exercisable 6,945
Options Exercisable [Member] | Exercise Price 0.40 [Member]  
Weighted Average Remaining Contractual life in years 5 years 3 months
Number Exercisable 3,334
v3.23.3
Net Loss Per Share (Details) - Schedule of Dilutive Shares - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Anti-dilutive shares 23,725,499 3,978,655 23,725,499 3,978,655
Convertible debt [Member]        
Anti-dilutive shares 13,046,469 491,290 13,046,469 491,290
Stock options [Member]        
Anti-dilutive shares 1,543,893 1,543,893 1,543,893 1,543,893
Warrants to purchase shares of common stock [Member]        
Anti-dilutive shares 9,135,137 1,943,472 9,135,137 1,943,472
v3.23.3
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 13, 2022
Sep. 13, 2022
Jul. 11, 2022
Jul. 11, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 21, 2023
Mr. Fuller [Member]                  
Related Party Transaction [Line Items]                  
Option expense         $ 0 $ 7,993 $ 0 $ 7,993  
Mr. Fuller [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares) 6,667                
Exercise price (in Dollars per share)   $ 1.2              
William Corbett [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares)       500,000          
Exercise price (in Dollars per share)     $ 4.5            
Option expense         66,587 890,441 199,760 1,023,614  
Working capital expenses                 $ 50,000
Clifford Henry [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares) 6,667                
Exercise price (in Dollars per share)   $ 1.2              
Option expense         0 7,993 0 7,993  
Financial and capital markets advice             3,500    
Common stock, value $ 7,993 $ 7,993              
Madisson Corbett [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares) 6,667                
Exercise price (in Dollars per share)   $ 1.2              
Option expense         0 7,993 0 7,993  
Common stock, value $ 7,993 $ 7,993              
David Rios [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares) 6,667                
Exercise price (in Dollars per share)   $ 1.2              
Option expense         0 7,993 0 7,993  
Common stock, value $ 7,993 $ 7,993              
Mr. Rosenblum [Member]                  
Related Party Transaction [Line Items]                  
Shares of common stock (in Shares)     66,667            
Option expense         $ 27,879 $ 27,879 $ 83,636 $ 83,636  
Common stock, value     $ 110,000 $ 110,000          
v3.23.3
Subsequent Events (Details) - USD ($)
Nov. 08, 2023
Oct. 20, 2023
Oct. 19, 2023
Sep. 30, 2023
Subsequent Event [Line Items]        
Issuance of convertible note       $ 238,182
Variable conversion rate       60.00%
Common Stock [Member]        
Subsequent Event [Line Items]        
Exercise price (in Dollars per share)       $ 0.0001
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Received net proceeds     $ 60,000  
Discount and fees     13,450  
Issuance of convertible note     $ 73,450  
Bearing interest percentage     13.00%  
Earned interest     $ 9,548  
Maturity date     Jul. 30, 2024  
Gross Proceeds   $ 50,000    
Bears interest   8.00%    
Subsequent Event [Member] | Warrant [Member]        
Subsequent Event [Line Items]        
Exercise price (in Dollars per share)   $ 0.345    
Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Conversion price (in Dollars per share)   $ 0.345    
Warrant [Member] | Subsequent Event [Member]        
Subsequent Event [Line Items]        
Purchase of aggregate shares (in Shares)   144,928    
Forecast [Member]        
Subsequent Event [Line Items]        
Accrued interest $ 100,000      
Conversion shares of common stock (in Shares) 289,855      
Conversion price per share (in Dollars per share) $ 0.345      

Innovative Payment Solut... (QB) (USOTC:IPSID)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Innovative Payment Solut... (QB) Charts.
Innovative Payment Solut... (QB) (USOTC:IPSID)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Innovative Payment Solut... (QB) Charts.